BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26:462-469. [PMID: 18362881 DOI: 10.1038/nbt1392] [Cited by in Crossref: 690] [Cited by in F6Publishing: 640] [Article Influence: 49.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, Wang TY, Li HC, Wu XN. Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett 2013;5:1639-42. [PMID: 23761828 DOI: 10.3892/ol.2013.1251] [Cited by in Crossref: 91] [Cited by in F6Publishing: 98] [Article Influence: 10.1] [Reference Citation Analysis]
2 Wang H, Peng R, Wang J, Qin Z, Xue L. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Clin Epigenetics 2018;10:59. [PMID: 29713393 DOI: 10.1186/s13148-018-0492-1] [Cited by in Crossref: 188] [Cited by in F6Publishing: 173] [Article Influence: 47.0] [Reference Citation Analysis]
3 McDermott R, Gabikian P, Sarvaiya P, Ulasov I, Lesniak MS. MicroRNAs in brain metastases: big things come in small packages. J Mol Med (Berl) 2013;91:5-13. [PMID: 23138927 DOI: 10.1007/s00109-012-0971-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
4 Han Y, Li H. miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC). J Thorac Dis. 2018;10:3119-3131. [PMID: 29997981 DOI: 10.21037/jtd.2018.05.32] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
5 Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101:2087-2092. [PMID: 20624164 DOI: 10.1111/j.1349-7006.2010.01650.x] [Cited by in Crossref: 863] [Cited by in F6Publishing: 813] [Article Influence: 71.9] [Reference Citation Analysis]
6 Spielmann N, Ilsley D, Gu J, Lea K, Brockman J, Heater S, Setterquist R, Wong DTW. The Human Salivary RNA Transcriptome Revealed by Massively Parallel Sequencing. Clinical Chemistry 2012;58:1314-21. [DOI: 10.1373/clinchem.2011.176941] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
7 Lithwick-Yanai G, Dromi N, Shtabsky A, Morgenstern S, Strenov Y, Feinmesser M, Kravtsov V, Leon ME, Hajdúch M, Ali SZ, VandenBussche CJ, Zhang X, Leider-Trejo L, Zubkov A, Vorobyov S, Kushnir M, Goren Y, Tabak S, Kadosh E, Benjamin H, Schnitzer-Perlman T, Marmor H, Motin M, Lebanony D, Kredo-Russo S, Mitchell H, Noller M, Smith A, Dattner O, Ashkenazi K, Sanden M, Berlin KA, Bar D, Meiri E. Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears. J Clin Pathol 2017;70:500-7. [PMID: 27798083 DOI: 10.1136/jclinpath-2016-204089] [Cited by in Crossref: 70] [Cited by in F6Publishing: 50] [Article Influence: 11.7] [Reference Citation Analysis]
8 Wang PY, Gao ZH, Jiang ZH, Li XX, Jiang BF, Xie SY. The associations of single nucleotide polymorphisms in miR-146a, miR-196a and miR-499 with breast cancer susceptibility. PLoS One. 2013;8:e70656. [PMID: 24039706 DOI: 10.1371/journal.pone.0070656] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
9 Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, Edmonston TB, Werner M, Lass U, Barshack I, Feinmesser M. A second-generation microRNA-based assay for diagnosing tumor tissue origin. Oncologist. 2012;17:801-812. [PMID: 22618571 DOI: 10.1634/theoncologist.2011-0466] [Cited by in Crossref: 102] [Cited by in F6Publishing: 87] [Article Influence: 10.2] [Reference Citation Analysis]
10 Galvão-Lima LJ, Morais AHF, Valentim RAM, Barreto EJSS. miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools. Biomed Eng Online 2021;20:21. [PMID: 33593374 DOI: 10.1186/s12938-021-00857-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Patnaik SK, Dahlgaard J, Mazin W, Kannisto E, Jensen T, Knudsen S, Yendamuri S. Expression of microRNAs in the NCI-60 cancer cell-lines. PLoS One 2012;7:e49918. [PMID: 23209617 DOI: 10.1371/journal.pone.0049918] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
12 Schotte D, Akbari Moqadam F, Lange-Turenhout EA, Chen C, van Ijcken WF, Pieters R, den Boer ML. Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia. Leukemia 2011;25:1389-99. [PMID: 21606961 DOI: 10.1038/leu.2011.105] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
13 Li B, Rao N, Liu D, Yang Y, Liu D, Li Y, Liu H, Gan T, Ding H, Lin H. Analysis of connection networks among miRNAs differentially expressed in early gastric cancer for disclosing some biological features of disease development. Gene 2014;548:159-65. [PMID: 25014139 DOI: 10.1016/j.gene.2014.07.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Yang H, Hui A, Pampalakis G, Soleymani L, Liu F, Sargent E, Kelley S. Direct, Electronic MicroRNA Detection for the Rapid Determination of Differential Expression Profiles. Angew Chem 2009;121:8613-6. [DOI: 10.1002/ange.200902577] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
15 Ling H, Calin GA. The Role of MicroRNAs and Ultraconserved Non-Coding RNAs in Cancer. Cancer Genomics. Elsevier; 2014. pp. 435-47. [DOI: 10.1016/b978-0-12-396967-5.00025-6] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Brodowski L, Schröder-Heurich B, von Hardenberg S, Richter K, von Kaisenberg CS, Dittrich-Breiholz O, Meyer N, Dörk T, von Versen-Höynck F. MicroRNA Profiles of Maternal and Neonatal Endothelial Progenitor Cells in Preeclampsia. Int J Mol Sci 2021;22:5320. [PMID: 34070163 DOI: 10.3390/ijms22105320] [Reference Citation Analysis]
17 Marrone AK, Beland FA, Pogribny IP. Noncoding RNA response to xenobiotic exposure: an indicator of toxicity and carcinogenicity. Expert Opin Drug Metab Toxicol 2014;10:1409-22. [PMID: 25171492 DOI: 10.1517/17425255.2014.954312] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
18 Murria Estal R, Palanca Suela S, de Juan Jiménez I, Egoavil Rojas C, García-Casado Z, Juan Fita MJ, Sánchez Heras AB, Segura Huerta A, Chirivella González I, Sánchez-Izquierdo D, Llop García M, Barragán González E, Bolufer Gilabert P. MicroRNA signatures in hereditary breast cancer. Breast Cancer Res Treat 2013;142:19-30. [PMID: 24129975 DOI: 10.1007/s10549-013-2723-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
19 Dorris ER, Smyth P, O'Leary JJ, Sheils O. MIR141 Expression Differentiates Hashimoto Thyroiditis from PTC and Benign Thyrocytes in Irish Archival Thyroid Tissues. Front Endocrinol (Lausanne) 2012;3:102. [PMID: 22969748 DOI: 10.3389/fendo.2012.00102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
20 Rapisuwon S, Vietsch EE, Wellstein A. Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J. 2016;14:211-222. [PMID: 27358717 DOI: 10.1016/j.csbj.2016.05.004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 13.8] [Reference Citation Analysis]
21 Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn. 2010;10:297-308. [PMID: 20370587 DOI: 10.1586/erm.10.11] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 14.7] [Reference Citation Analysis]
22 Masui K, Cloughesy TF, Mischel PS. Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies. Neuropathol Appl Neurobiol 2012;38:271-91. [PMID: 22098029 DOI: 10.1111/j.1365-2990.2011.01238.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
23 da Cruz AT, Jasiulionis MG. miRNAs and Melanoma: How Are They Connected? Dermatol Res Pract 2012;2012:528345. [PMID: 21860617 DOI: 10.1155/2012/528345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
24 Rossing M, Borup R, Henao R, Winther O, Vikesaa J, Niazi O, Godballe C, Krogdahl A, Glud M, Hjort-Sørensen C, Kiss K, Bennedbæk FN, Nielsen FC. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma. J Mol Endocrinol 2012;48:11-23. [PMID: 22049245 DOI: 10.1530/JME-11-0039] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
25 Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, Barabash N, Ashkenazi K, Goren E, Meiri E, Morgenstern S, Perelman M, Barshack I, Goren Y, Edmonston TB, Chajut A, Aharonov R, Bentwich Z, Rosenfeld N, Cohen D. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 2010;12:771-9. [PMID: 20864637 DOI: 10.2353/jmoldx.2010.090169] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 6.4] [Reference Citation Analysis]
26 Yin CQ, Yuan CH, Qu Z, Guan Q, Chen H, Wang FB. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers. Dis Markers. 2016;2016:1427849. [PMID: 27403030 DOI: 10.1155/2016/1427849] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
27 Zeng JH, Liang XZ, Lan HH, Zhu X, Liang XY. The biological functions of target genes in pan-cancers and cell lines were predicted by miR-375 microarray data from GEO database and bioinformatics. PLoS One 2018;13:e0206689. [PMID: 30379973 DOI: 10.1371/journal.pone.0206689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Slaby O, Svoboda M, Michalek J, Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer. 2009;8:102. [PMID: 19912656 DOI: 10.1186/1476-4598-8-102] [Cited by in Crossref: 243] [Cited by in F6Publishing: 244] [Article Influence: 18.7] [Reference Citation Analysis]
29 Spector Y, Fridman E, Rosenwald S, Zilber S, Huang Y, Barshack I, Zion O, Mitchell H, Sanden M, Meiri E. Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas. Mol Oncol 2013;7:732-8. [PMID: 23587442 DOI: 10.1016/j.molonc.2013.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
30 Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, Faerman A, Benjamin H, Tamir R, Ezagouri M, Goren E. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Mod Pathol. 2010;23:814-823. [PMID: 20348879 DOI: 10.1038/modpathol.2010.57] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 7.5] [Reference Citation Analysis]
31 Nanayakkara J, Tyryshkin K, Yang X, Wong JJM, Vanderbeck K, Ginter PS, Scognamiglio T, Chen YT, Panarelli N, Cheung NK, Dijk F, Ben-Dov IZ, Kim MK, Singh S, Morozov P, Max KEA, Tuschl T, Renwick N. Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining. NAR Cancer 2020;2:zcaa009. [PMID: 32743554 DOI: 10.1093/narcan/zcaa009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012;482:347-355. [PMID: 22337054 DOI: 10.1038/nature1088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Park EC, Kim G, Jung J, Wang K, Lee S, Jeon SS, Lee ZW, Kim SI, Kim S, Oh YT. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy. OMICS. 2013;17:259-268. [PMID: 23586679 DOI: 10.1089/omi.2012.0065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
34 Chira P, Vareli K, Sainis I, Papandreou C, Briasoulis E. Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value. Cancers (Basel) 2010;2:1328-53. [PMID: 24281118 DOI: 10.3390/cancers2021328] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
35 Bell RE, Khaled M, Netanely D, Schubert S, Golan T, Buxbaum A, Janas MM, Postolsky B, Goldberg MS, Shamir R, Levy C. Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1. Journal of Investigative Dermatology 2014;134:441-51. [DOI: 10.1038/jid.2013.340] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 9.3] [Reference Citation Analysis]
36 Sedani A, Cooper DN, Upadhyaya M. An emerging role for microRNAs in NF1 tumorigenesis. Hum Genomics 2012;6:23. [PMID: 23158014 DOI: 10.1186/1479-7364-6-23] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
37 Song FJ, Chen KX. Single-nucleotide polymorphisms among microRNA: big effects on cancer. Chin J Cancer 2011;30:381-91. [PMID: 21627860 DOI: 10.5732/cjc.011.10142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
38 Pando R, Even-Zohar N, Shtaif B, Edry L, Shomron N, Phillip M, Gat-Yablonski G. MicroRNAs in the growth plate are responsive to nutritional cues: association between miR-140 and SIRT1. J Nutr Biochem 2012;23:1474-81. [PMID: 22402365 DOI: 10.1016/j.jnutbio.2011.09.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
39 Bedi K, Paulsen MT, Wilson TE, Ljungman M. Characterization of novel primary miRNA transcription units in human cells using Bru-seq nascent RNA sequencing. NAR Genom Bioinform 2020;2:lqz014. [PMID: 31709421 DOI: 10.1093/nargab/lqz014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Yao Y, Zhao Y, Smith LP, Lawrie CH, Saunders NJ, Watson M, Nair V. Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. J Gen Virol 2009;90:1551-9. [PMID: 19297609 DOI: 10.1099/vir.0.009902-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
41 Li C, Hu J, Zou X, Luo X, Zhang C. Construction of a Structure-Switchable Toehold Dumbbell Probe for Sensitive and Label-Free Measurement of MicroRNA in Cancer Cells and Tissues. Anal Chem . [DOI: 10.1021/acs.analchem.1c05066] [Reference Citation Analysis]
42 Zhang XJ, Ye H, Zeng CW, He B, Zhang H, Chen YQ. Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol. 2010;3:46. [PMID: 21106054 DOI: 10.1186/1756-8722-3-46] [Cited by in Crossref: 137] [Cited by in F6Publishing: 134] [Article Influence: 11.4] [Reference Citation Analysis]
43 Wan C, Shen Y, Yang T, Wang T, Chen L, Wen F. Diagnostic value of microRNA for pancreatic cancer: a meta-analysis. Arch Med Sci. 2012;8:749-755. [PMID: 23185182 DOI: 10.5114/aoms.2012.31609] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
44 Moll R. [The initial CUP situation and CUP syndrome: pathological diagnostics]. Pathologe 2009;30 Suppl 2:161-7. [PMID: 19816686 DOI: 10.1007/s00292-009-1193-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
45 Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Clin Chem 2009;55:623-31. [PMID: 19246618 DOI: 10.1373/clinchem.2008.112805] [Cited by in Crossref: 388] [Cited by in F6Publishing: 349] [Article Influence: 29.8] [Reference Citation Analysis]
46 Lussier YA, Stadler WM, Chen JL. Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures. J Am Med Inform Assoc 2012;19:156-60. [PMID: 22101905 DOI: 10.1136/amiajnl-2011-000419] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
47 Muluhngwi P, Klinge CM. Roles for miRNAs in endocrine resistance in breast cancer. Endocr Relat Cancer. 2015;22:R279-R300. [PMID: 26346768 DOI: 10.1530/erc-15-0355] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
48 Bautista-Sánchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Velázquez IA, González-Barrios R, Contreras-Espinosa L, Montiel-Manríquez R, Castro-Hernández C, Fragoso-Ontiveros V, Álvarez-Gómez RM, Herrera LA. The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics. Mol Ther Nucleic Acids 2020;20:409-20. [PMID: 32244168 DOI: 10.1016/j.omtn.2020.03.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
49 Swaid F, Downs D, Rosemurgy AS. A practical approach to liver metastasis from unknown primary cancer: What surgeons need to know. Cancer Genetics 2016;209:559-66. [DOI: 10.1016/j.cancergen.2016.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
50 Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8:467-477. [PMID: 21647195 DOI: 10.1038/nrclinonc.2011.76] [Cited by in Crossref: 916] [Cited by in F6Publishing: 890] [Article Influence: 83.3] [Reference Citation Analysis]
51 Glud M, Klausen M, Gniadecki R, Rossing M, Hastrup N, Nielsen FC, Drzewiecki KT. MicroRNA Expression in Melanocytic Nevi: The Usefulness of Formalin-Fixed, Paraffin-Embedded Material for miRNA Microarray Profiling. Journal of Investigative Dermatology 2009;129:1219-24. [DOI: 10.1038/jid.2008.347] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
52 Tang T, Su R, Wang B, Zhang Y. An integrated approach of predicted miR-34a targets identifies a signature for gastric cancer. Oncol Lett 2015;10:653-60. [PMID: 26622549 DOI: 10.3892/ol.2015.3266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
53 Ben-Shushan D, Markovsky E, Gibori H, Tiram G, Scomparin A, Satchi-Fainaro R. Overcoming obstacles in microRNA delivery towards improved cancer therapy. Drug Deliv Transl Res 2014;4:38-49. [PMID: 25786616 DOI: 10.1007/s13346-013-0160-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
54 Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3:e3148. [PMID: 18773077 DOI: 10.1371/journal.pone.0003148] [Cited by in Crossref: 934] [Cited by in F6Publishing: 912] [Article Influence: 66.7] [Reference Citation Analysis]
55 Ohlsson Teague EMC, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Human Reproduction Update 2010;16:142-65. [DOI: 10.1093/humupd/dmp034] [Cited by in Crossref: 177] [Cited by in F6Publishing: 175] [Article Influence: 13.6] [Reference Citation Analysis]
56 Wu J, Hu S, Zhang L, Xin J, Sun C, Wang L, Ding K, Wang B. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis. Theranostics 2020;10:4544-56. [PMID: 32292514 DOI: 10.7150/thno.40532] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
57 Wu Q, Wang H, Gong K, Shang J, Liu X, Wang F. Construction of an Autonomous Nonlinear Hybridization Chain Reaction for Extracellular Vesicles-Associated MicroRNAs Discrimination. Anal Chem 2019;91:10172-9. [PMID: 31288510 DOI: 10.1021/acs.analchem.9b02181] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
58 Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, Gilson G, Corsten MF, Schroen B, Lair ML, Heymans S. Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem. 2012;58:559-567. [PMID: 22252325 DOI: 10.1373/clinchem.2011.173823] [Cited by in Crossref: 169] [Cited by in F6Publishing: 158] [Article Influence: 16.9] [Reference Citation Analysis]
59 Miao P, Jiang Y, Zhang T, Huang Y, Tang Y. Electrochemical sensing of attomolar miRNA combining cascade strand displacement polymerization and reductant-mediated amplification. Chem Commun 2018;54:7366-9. [DOI: 10.1039/c8cc03698e] [Cited by in Crossref: 25] [Cited by in F6Publishing: 1] [Article Influence: 6.3] [Reference Citation Analysis]
60 Sun Z, Zhang T, Hong H, Liu Q, Zhang H. miR-202 suppresses proliferation and induces apoptosis of osteosarcoma cells by downregulating Gli2. Mol Cell Biochem 2014;397:277-83. [DOI: 10.1007/s11010-014-2195-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
61 Siva AC, Nelson LJ, Fleischer CL, Majlessi M, Becker MM, Vessella RL, Reynolds MA. Molecular assays for the detection of microRNAs in prostate cancer. Mol Cancer 2009;8:17. [PMID: 19267923 DOI: 10.1186/1476-4598-8-17] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
62 Zeng J, Wei M, Shi R, Cai C, Liu X, Li T, Ma W. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer. Tumour Biol 2016;37:2729-35. [PMID: 26408179 DOI: 10.1007/s13277-015-4039-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
63 Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol. 2012;29:618-626. [PMID: 21516486 DOI: 10.1007/s12032-011-9923-y] [Cited by in Crossref: 162] [Cited by in F6Publishing: 154] [Article Influence: 14.7] [Reference Citation Analysis]
64 Shalaby T, Fiaschetti G, Baumgartner M, Grotzer MA. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons. Int J Mol Sci 2014;15:21554-86. [PMID: 25421247 DOI: 10.3390/ijms151121554] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
65 Loosen SH, Neumann UP, Trautwein C, Roderburg C, Luedde T. Current and future biomarkers for pancreatic adenocarcinoma. Tumour Biol 2017;39:101042831769223. [DOI: 10.1177/1010428317692231] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
66 Bobbili MR, Mader RM, Grillari J, Dellago H. OncomiR-17-5p: alarm signal in cancer? Oncotarget 2017;8:71206-22. [PMID: 29050357 DOI: 10.18632/oncotarget.19331] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
67 Cortez MA, Ivan C, Zhou P, Wu X, Ivan M, Calin GA. microRNAs in cancer: from bench to bedside. Adv Cancer Res. 2010;108:113-157. [PMID: 21034967 DOI: 10.1016/b978-0-12-380888-2.00004-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
68 Oien KA. Pathologic evaluation of unknown primary cancer. Semin Oncol 2009;36:8-37. [PMID: 19179185 DOI: 10.1053/j.seminoncol.2008.10.009] [Cited by in Crossref: 135] [Cited by in F6Publishing: 104] [Article Influence: 10.4] [Reference Citation Analysis]
69 Tuncturk FR, Akalin I, Uzun L, Zenginkinet T. Comparison of miRNA expressions among benign, premalignant and malignant lesions of the larynx: could they be transformation biomarkers? J Otolaryngol Head Neck Surg 2021;50:14. [PMID: 33640023 DOI: 10.1186/s40463-021-00497-y] [Reference Citation Analysis]
70 Ivanov SV, Goparaju CM, Lopez P, Zavadil J, Toren-Haritan G, Rosenwald S, Hoshen M, Chajut A, Cohen D, Pass HI. Pro-tumorigenic effects of miR-31 loss in mesothelioma. J Biol Chem 2010;285:22809-17. [PMID: 20463022 DOI: 10.1074/jbc.M110.100354] [Cited by in Crossref: 92] [Cited by in F6Publishing: 61] [Article Influence: 7.7] [Reference Citation Analysis]
71 Rossing M, Kaczkowski B, Futoma-kazmierczak E, Glud M, Klausen M, Faber J, Nygaard B, Kiss K, Sørensen CH, Nielsen FC, Bennedbæk FN, Friis-hansen L. A simple procedure for routine RNA extraction and miRNA array analyses from a single thyroid in vivo fine needle aspirate. Scandinavian Journal of Clinical and Laboratory Investigation 2010;70:529-34. [DOI: 10.3109/00365513.2010.522250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
72 Yadav RP, Kotaja N. Small RNAs in spermatogenesis. Molecular and Cellular Endocrinology 2014;382:498-508. [DOI: 10.1016/j.mce.2013.04.015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 10.8] [Reference Citation Analysis]
73 Greco FA, Oien K, Erlander M, Osborne R, Varadhachary G, Bridgewater J, Cohen D, Wasan H. Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes. Ann Oncol 2012;23:298-304. [PMID: 21709138 DOI: 10.1093/annonc/mdr306] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
74 Ralfkiaer U, Hagedorn PH, Bangsgaard N, Løvendorf MB, Ahler CB, Svensson L, Kopp KL, Vennegaard MT, Lauenborg B, Zibert JR, Krejsgaard T, Bonefeld CM, Søkilde R, Gjerdrum LM, Labuda T, Mathiesen AM, Grønbæk K, Wasik MA, Sokolowska-Wojdylo M, Queille-Roussel C, Gniadecki R, Ralfkiaer E, Geisler C, Litman T, Woetmann A, Glue C, Røpke MA, Skov L, Odum N. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 2011;118:5891-900. [PMID: 21865341 DOI: 10.1182/blood-2011-06-358382] [Cited by in Crossref: 172] [Cited by in F6Publishing: 157] [Article Influence: 15.6] [Reference Citation Analysis]
75 Adam-Artigues A, Garrido-Cano I, Simón S, Ortega B, Moragón S, Lameirinhas A, Constâncio V, Salta S, Burgués O, Bermejo B, Henrique R, Lluch A, Jerónimo C, Eroles P, Cejalvo JM. Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer. ESMO Open 2021;6:100039. [PMID: 33477007 DOI: 10.1016/j.esmoop.2020.100039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
76 Dolled-Filhart MP, Rimm DL. Gene expression array analysis to determine tissue of origin of carcinoma of unknown primary: cutting edge or already obsolete? Cancer Cytopathol 2013;121:129-35. [PMID: 22927160 DOI: 10.1002/cncy.21228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
77 Segura MF, Belitskaya-Lévy I, Rose AE, Zakrzewski J, Gaziel A, Hanniford D, Darvishian F, Berman RS, Shapiro RL, Pavlick AC, Osman I, Hernando E. Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res 2010;16:1577-86. [PMID: 20179230 DOI: 10.1158/1078-0432.CCR-09-2721] [Cited by in Crossref: 162] [Cited by in F6Publishing: 79] [Article Influence: 13.5] [Reference Citation Analysis]
78 Glud M, Gniadecki R. MicroRNAs in the pathogenesis of malignant melanoma. J Eur Acad Dermatol Venereol 2013;27:142-50. [PMID: 22621697 DOI: 10.1111/j.1468-3083.2012.04579.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
79 Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, Watanabe M, Nakagama H, Yokota J, Kohno T, Tsuchiya N. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014;9:e92921. [PMID: 24705249 DOI: 10.1371/journal.pone.0092921] [Cited by in Crossref: 486] [Cited by in F6Publishing: 453] [Article Influence: 60.8] [Reference Citation Analysis]
80 Reichenstein I, Aizenberg N, Goshen M, Bentwich Z, Avni YS. A novel qPCR assay for viral encoded microRNAs. Journal of Virological Methods 2010;163:323-8. [DOI: 10.1016/j.jviromet.2009.10.018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
81 Wu C, Lin J, Hong M, Choudhury Y, Balani P, Leung D, Dang LH, Zhao Y, Zeng J, Wang S. Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy. Mol Ther. 2009;17:2058-2066. [PMID: 19809402 DOI: 10.1038/mt.2009.225] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
82 Pietrus M, Seweryn M, Kapusta P, Wołkow P, Pityński K, Wątor G. Low Expression of miR-375 and miR-190b Differentiates Grade 3 Patients with Endometrial Cancer. Biomolecules 2021;11:274. [PMID: 33668431 DOI: 10.3390/biom11020274] [Reference Citation Analysis]
83 Löffler H, Neben K, Krämer A. [Cancer of unknown primary. Epidemiology and pathogenesis]. Radiologe 2014;54:107-11. [PMID: 24435156 DOI: 10.1007/s00117-013-2544-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
84 Ma YY, Tao HQ. Microribonucleic acids and gastric cancer. Cancer Sci 2012;103:620-5. [PMID: 22168593 DOI: 10.1111/j.1349-7006.2011.02185.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
85 Huang W. MicroRNAs: Biomarkers, Diagnostics, and Therapeutics. Methods Mol Biol. 2017;1617:57-67. [PMID: 28540676 DOI: 10.1007/978-1-4939-7046-9_4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
86 Brody EN, Gold L, Lawn RM, Walker JJ, Zichi D. High-content affinity-based proteomics: unlocking protein biomarker discovery. Expert Rev Mol Diagn 2010;10:1013-22. [PMID: 21080818 DOI: 10.1586/erm.10.89] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
87 Ishikawa H, Yamada H, Taromaru N, Kondo K, Nagura A, Yamazaki M, Ando Y, Munetsuna E, Suzuki K, Ohashi K, Teradaira R. Stability of serum high-density lipoprotein-microRNAs for preanalytical conditions. Ann Clin Biochem. 2017;54:134-142. [PMID: 27166305 DOI: 10.1177/0004563216647086] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
88 Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One. 2009;4:e8003. [PMID: 19946373 DOI: 10.1371/journal.pone.0008003] [Cited by in Crossref: 125] [Cited by in F6Publishing: 129] [Article Influence: 9.6] [Reference Citation Analysis]
89 Hodzic J, Sie D, Vermeulen A, van Beusechem VW. Functional Screening Identifies Human miRNAs that Modulate Adenovirus Propagation in Prostate Cancer Cells. Hum Gene Ther 2017;28:766-80. [PMID: 28114818 DOI: 10.1089/hum.2016.143] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
90 Ji H, Sang M, Liu F, Ai N, Geng C. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer. Pathol Res Pract 2019;215:697-704. [PMID: 30611621 DOI: 10.1016/j.prp.2018.12.039] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
91 Wang J, Zhang KY, Liu SM, Sen S. Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules. 2014;19:1912-1938. [PMID: 24518808 DOI: 10.3390/molecules19021912] [Cited by in Crossref: 104] [Cited by in F6Publishing: 104] [Article Influence: 13.0] [Reference Citation Analysis]
92 Pfeifer A, Lehmann H. Pharmacological potential of RNAi--focus on miRNA. Pharmacol Ther 2010;126:217-27. [PMID: 20388525 DOI: 10.1016/j.pharmthera.2010.03.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
93 Pillai R, Deeter R, Rigl CT, Nystrom JS, Miller MH, Buturovic L, Henner WD. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens. J Mol Diagn 2011;13:48-56. [PMID: 21227394 DOI: 10.1016/j.jmoldx.2010.11.001] [Cited by in Crossref: 89] [Cited by in F6Publishing: 74] [Article Influence: 7.4] [Reference Citation Analysis]
94 Kishikawa T, Otsuka M, Ohno M, Yoshikawa T, Takata A, Koike K. Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J Gastroenterol 2015; 21(28): 8527-8540 [PMID: 26229396 DOI: 10.3748/wjg.v21.i28.8527] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 89] [Article Influence: 13.1] [Reference Citation Analysis]
95 Manservigi R, Argnani R, Marconi P. HSV Recombinant Vectors for Gene Therapy. Open Virol J 2010;4:123-56. [PMID: 20835362 DOI: 10.2174/1874357901004030123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Wu L, Hu B, Zhao B, Liu Y, Yang Y, Zhang L, Chen J. Circulating microRNA-422a is associated with lymphatic metastasis in lung cancer. Oncotarget 2017;8:42173-88. [PMID: 28178679 DOI: 10.18632/oncotarget.15025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
97 Zhu W, Qin W, Atasoy U, Sauter ER. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes. 2009;2:89. [PMID: 19454029 DOI: 10.1186/1756-0500-2-89] [Cited by in Crossref: 264] [Cited by in F6Publishing: 257] [Article Influence: 20.3] [Reference Citation Analysis]
98 Greco FA. Molecular Diagnosis of the Tissue of Origin in Cancer of Unknown Primary Site: Useful in Patient Management. Curr Treat Options in Oncol 2013;14:634-42. [DOI: 10.1007/s11864-013-0257-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
99 Han Y, Chen J, Zhao X, Liang C, Wang Y, Sun L, Jiang Z, Zhang Z, Yang R, Chen J. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One. 2011;6:e18286. [PMID: 21464941 DOI: 10.1371/journal.pone.0018286] [Cited by in Crossref: 179] [Cited by in F6Publishing: 180] [Article Influence: 16.3] [Reference Citation Analysis]
100 Thieu W, Tilki D, de Vere White R, Evans CP. The role of microRNA in castration-resistant prostate cancer. Urol Oncol 2014;32:517-23. [PMID: 24935732 DOI: 10.1016/j.urolonc.2013.11.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
101 Shirjang S, Mansoori B, Asghari S, Duijf PHG, Mohammadi A, Gjerstorff M, Baradaran B. MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis. Free Radic Biol Med 2019;139:1-15. [PMID: 31102709 DOI: 10.1016/j.freeradbiomed.2019.05.017] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 21.3] [Reference Citation Analysis]
102 Zhou X, Zhang X, Yang Y, Li Z, Du L, Dong Z, Qu A, Jiang X, Li P, Wang C. Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer. Med Oncol. 2014;31:197. [PMID: 25168920 DOI: 10.1007/s12032-014-0197-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
103 Vincent M, Perell K, Nielsen FC, Daugaard G, Hansen NR. Modeling tissue contamination to improve molecular identification of the primary tumor site of metastases. Bioinformatics 2014;30:1417-23. [PMID: 24463184 DOI: 10.1093/bioinformatics/btu044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
104 Niland CN, Merry CR, Khalil AM. Emerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders. Front Genet 2012;3:25. [PMID: 22375145 DOI: 10.3389/fgene.2012.00025] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
105 Hydbring P, Badalian-Very G. Clinical applications of microRNAs. F1000Res 2013;2:136. [PMID: 24627783 DOI: 10.12688/f1000research.2-136.v3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 70] [Article Influence: 2.2] [Reference Citation Analysis]
106 Ferracin M, Calin GA. Principles of MicroRNA Involvement in Breast Cancer. Breast Diseases: A Year Book Quarterly 2011;22:238-43. [DOI: 10.1016/j.breastdis.2011.06.052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
107 Rengaswamy V, Kontny U, Rössler J. New approaches for pediatric rhabdomyosarcoma drug discovery: targeting combinatorial signaling. Expert Opin Drug Discov 2011;6:1103-25. [PMID: 22646865 DOI: 10.1517/17460441.2011.611498] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Hemida MG, Ye X, Thair S, Yang D. Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations. Mol Diagn Ther 2010;14:271-82. [PMID: 21053993 DOI: 10.1007/BF03256383] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
109 Yin Z, Cui Z, Ren Y, Xia L, Li H, Zhou B. MiR-196a2 and lung cancer in Chinese non-smoking females: a genetic association study and expression analysis. Oncotarget 2017;8:70890-8. [PMID: 29050330 DOI: 10.18632/oncotarget.20174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
110 Cui Y, Fan S, Yuan Z, Song M, Hu J, Qian D, Zhen D, Li J, Zhu B. Ultrasensitive electrochemical assay for microRNA-21 based on CRISPR/Cas13a-assisted catalytic hairpin assembly. Talanta 2021;224:121878. [PMID: 33379087 DOI: 10.1016/j.talanta.2020.121878] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
111 Bates S. The role of gene expression profiling in drug discovery. Curr Opin Pharmacol 2011;11:549-56. [PMID: 21752712 DOI: 10.1016/j.coph.2011.06.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
112 Donzelli S, Cioce M, Muti P, Strano S, Yarden Y, Blandino G. MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer. Semin Cell Dev Biol 2016;50:133-42. [PMID: 26773212 DOI: 10.1016/j.semcdb.2015.12.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
113 Swanton C, Caldas C. Molecular classification of solid tumours: towards pathway-driven therapeutics. Br J Cancer 2009;100:1517-22. [PMID: 19367275 DOI: 10.1038/sj.bjc.6605031] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
114 Saini S, Arora S, Majid S, Hirata H, Dahiya R. MicroRNAs in the Development and Progression of Kidney Cancer. In: Singh SR, Rameshwar P, editors. MicroRNA in Development and in the Progression of Cancer. New York: Springer; 2014. pp. 213-41. [DOI: 10.1007/978-1-4899-8065-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Chen X, Zhang J, Zen K, Zhang C. MicroRNAs as Blood-based Biomarkers of Cancer. In: Cho WC, editor. MicroRNAs in Cancer Translational Research. Dordrecht: Springer Netherlands; 2011. pp. 499-532. [DOI: 10.1007/978-94-007-0298-1_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
116 Bissonnette MLZ, Kocherginsky M, Tretiakova M, Jimenez RE, Barkan GA, Mehta V, Sirintrapun SJ, Steinberg GD, White KP, Stricker T, Paner GP. The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling. Human Pathology 2013;44:1605-11. [DOI: 10.1016/j.humpath.2013.01.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
117 Truini A, Coco S, Alama A, Genova C, Sini C, Dal Bello MG, Barletta G, Rijavec E, Burrafato G, Boccardo F, Grossi F. Role of microRNAs in malignant mesothelioma. Cell Mol Life Sci 2014;71:2865-78. [PMID: 24562347 DOI: 10.1007/s00018-014-1584-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
118 Chang NW, Dai HJ, Shih YY, Wu CY, Dela Rosa MAC, Obena RP, Chen YJ, Hsu WL, Oyang YJ. Biomarker identification of hepatocellular carcinoma using a methodical literature mining strategy. Database (Oxford) 2017;2017:bax082. [PMID: 31725857 DOI: 10.1093/database/bax082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
119 Scapoli L, Palmieri A, Muzio LL, Pezzetti F, Rubini C, Girardi A, Farinella F, Mazzotta M, Carinci F. MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression. Int J Immunopathol Pharmacol 2010;23:1229-34. [DOI: 10.1177/039463201002300427] [Cited by in Crossref: 164] [Cited by in F6Publishing: 161] [Article Influence: 13.7] [Reference Citation Analysis]
120 Hromadnikova I, Kotlabova K, Dvorakova L, Krofta L, Sirc J. Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications. Int J Mol Sci 2019;20:E654. [PMID: 30717412 DOI: 10.3390/ijms20030654] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
121 Hackl M, Heilmeier U, Weilner S, Grillari J. Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases? Mol Cell Endocrinol 2016;432:83-95. [PMID: 26525415 DOI: 10.1016/j.mce.2015.10.015] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 12.1] [Reference Citation Analysis]
122 Varella-Garcia M. Chromosomal and genomic changes in lung cancer. Cell Adh Migr 2010;4:100-6. [PMID: 20139701 DOI: 10.4161/cam.4.1.10884] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
123 Skreka K, Zywicki M, Karbiener M, Hüttenhofer A, Scheideler M, Rederstorff M. Expression Profiling of a Heterogeneous Population of ncRNAs Employing a Mixed DNA/LNA Microarray. J Nucleic Acids 2012;2012:283560. [PMID: 22778910 DOI: 10.1155/2012/283560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
124 Xiong Y, Kotian S, Zeiger MA, Zhang L, Kebebew E. miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer. PLoS One 2015;10:e0130496. [PMID: 26244545 DOI: 10.1371/journal.pone.0130496] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
125 Mostert B, Sieuwerts AM, Martens JW, Sleijfer S. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients. Expert Rev Mol Diagn. 2011;11:259-275. [PMID: 21463236 DOI: 10.1586/erm.11.11] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
126 Bo B, Zhang T, Jiang Y, Cui H, Miao P. Triple Signal Amplification Strategy for Ultrasensitive Determination of miRNA Based on Duplex Specific Nuclease and Bridge DNA–Gold Nanoparticles. Anal Chem 2018;90:2395-400. [DOI: 10.1021/acs.analchem.7b05447] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 19.5] [Reference Citation Analysis]
127 Wright K, Plain K, Purdie A, Saunders BM, de Silva K. Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals. Infect Immun 2019;88:e00401-19. [PMID: 31527123 DOI: 10.1128/IAI.00401-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
128 Chen QY, Jiao DM, Wu YQ, Wang L, Hu HZ, Song J, Yan J, Wu LJ. Functional and pathway enrichment analysis for integrated regulatory network of high- and low-metastatic lung cancer. Mol Biosyst 2013;9:3080-90. [PMID: 24077187 DOI: 10.1039/c3mb70288j] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
129 Aldridge S, Hadfield J. Introduction to miRNA Profiling Technologies and Cross-Platform Comparison. In: Fan J, editor. Next-Generation MicroRNA Expression Profiling Technology. Totowa: Humana Press; 2012. pp. 19-31. [DOI: 10.1007/978-1-61779-427-8_2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
130 Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 2012;32:326-348. [PMID: 22383180 DOI: 10.1002/med.20215] [Cited by in Crossref: 319] [Cited by in F6Publishing: 303] [Article Influence: 26.6] [Reference Citation Analysis]
131 Ferrier DC, Shaver MP, Hands PJ. Conductive composites for oligonucleotide detection. Sensing and Bio-Sensing Research 2018;17:1-6. [DOI: 10.1016/j.sbsr.2017.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
132 Ben-Dov IZ, Tan YC, Morozov P, Wilson PD, Rennert H, Blumenfeld JD, Tuschl T. Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline. PLoS One 2014;9:e86856. [PMID: 24489795 DOI: 10.1371/journal.pone.0086856] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
133 Di Leva G, Croce CM. miRNA profiling of cancer. Curr Opin Genet Dev. 2013;23:3-11. [PMID: 23465882 DOI: 10.1016/j.gde.2013.01.004] [Cited by in Crossref: 243] [Cited by in F6Publishing: 237] [Article Influence: 27.0] [Reference Citation Analysis]
134 Krauss S, Evert BO. The Role of MicroRNAs in Spinocerebellar Ataxia Type 3. J Mol Biol 2019;431:1729-42. [PMID: 30664869 DOI: 10.1016/j.jmb.2019.01.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
135 Cui M, Wang H, Yao X, Zhang D, Xie Y, Cui R, Zhang X. Circulating MicroRNAs in Cancer: Potential and Challenge. Front Genet 2019;10:626. [PMID: 31379918 DOI: 10.3389/fgene.2019.00626] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 31.7] [Reference Citation Analysis]
136 Boix L, López-Oliva JM, Rhodes AC, Bruix J. Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-β pathway. Oncotarget 2016;7:71309-29. [PMID: 27612430 DOI: 10.18632/oncotarget.11885] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
137 Chatterjee A, Leichter AL, Fan V, Tsai P, Purcell RV, Sullivan MJ, Eccles MR. A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patients. Sci Rep 2015;5:10438. [PMID: 26039282 DOI: 10.1038/srep10438] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
138 Robinson VL. Rethinking the central dogma: noncoding RNAs are biologically relevant. Urol Oncol 2009;27:304-6. [PMID: 19414118 DOI: 10.1016/j.urolonc.2008.11.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
139 Zaleska K. miRNA - Therapeutic tool in breast cancer? Where are we now? Rep Pract Oncol Radiother 2015;20:79-86. [PMID: 25859396 DOI: 10.1016/j.rpor.2014.10.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
140 Rossing M. Classification of follicular cell-derived thyroid cancer by global RNA profiling. J Mol Endocrinol 2013;50:R39-51. [PMID: 23355745 DOI: 10.1530/JME-12-0170] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
141 Mardin WA, Mees ST. MicroRNAs: Novel Diagnostic and Therapeutic Tools for Pancreatic Ductal Adenocarcinoma? Ann Surg Oncol 2009;16:3183-9. [DOI: 10.1245/s10434-009-0623-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
142 Chen C, Tan R, Wong L, Fekete R, Halsey J. Quantitation of microRNAs by real-time RT-qPCR. Methods Mol Biol 2011;687:113-34. [PMID: 20967604 DOI: 10.1007/978-1-60761-944-4_8] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
143 Vietsch EE, van Eijck CH, Wellstein A. Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer. Pancreat Disord Ther. 2015;5. [PMID: 26161297 DOI: 10.4172/2165-7092.1000156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
144 Zhang BC, Zhang J, Sun L. In-depth profiling and analysis of host and viral microRNAs in Japanese flounder (Paralichthys olivaceus) infected with megalocytivirus reveal involvement of microRNAs in host-virus interaction in teleost fish. BMC Genomics 2014;15:878. [PMID: 25297525 DOI: 10.1186/1471-2164-15-878] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 7.6] [Reference Citation Analysis]
145 Arnold M, Ellwanger DC, Hartsperger ML, Pfeufer A, Stümpflen V. Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways. PLoS One 2012;7:e36694. [PMID: 22606281 DOI: 10.1371/journal.pone.0036694] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
146 Pan CY, Kuo WT, Chiu CY, Lin WC. Visual Display of 5p-arm and 3p-arm miRNA Expression with a Mobile Application. Biomed Res Int 2017;2017:6037168. [PMID: 28271066 DOI: 10.1155/2017/6037168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
147 Qin LX, Tuschl T, Singer S. An Empirical Evaluation of Normalization Methods for MicroRNA Arrays in a Liposarcoma Study. Cancer Inform 2013;12:83-101. [PMID: 23589668 DOI: 10.4137/CIN.S11384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
148 Corsini LR, Bronte G, Terrasi M, Amodeo V, Fanale D, Fiorentino E, Cicero G, Bazan V, Russo A. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opin Ther Targets. 2012;16 Suppl 2:S103-S109. [PMID: 22443195 DOI: 10.1517/14728222.2011.650632] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 7.8] [Reference Citation Analysis]
149 Alshareeda AT, Al-Sowayan BS, Alkharji RR, Aldosari SM, Al Subayyil AM, Alghuwainem A. Cancer of Unknown Primary Site: Real Entity or Misdiagnosed Disease? J Cancer 2020;11:3919-31. [PMID: 32328196 DOI: 10.7150/jca.42880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
150 Nonaka T, Wong DTW. Liquid Biopsy in Head and Neck Cancer: Promises and Challenges. J Dent Res 2018;97:701-8. [PMID: 29513618 DOI: 10.1177/0022034518762071] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 10.5] [Reference Citation Analysis]
151 Matsushima K, Isomoto H, Yamaguchi N, Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S, Nagayasu T, Nakashima M, Ujifuku K, Mitsutake N, Ohtsuru A, Yamashita S, Korpal M, Kang Y, Gregory PA, Goodall GJ, Kohno S, Nakao K. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J Transl Med. 2011;9:30. [PMID: 21426561 DOI: 10.1186/1479-5876-9-30] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 8.9] [Reference Citation Analysis]
152 Lampignano R, Kloten V, Krahn T, Schlange T. Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future? Molecular Aspects of Medicine 2020;72:100844. [DOI: 10.1016/j.mam.2020.100844] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
153 Luo Z, Li X, Zhao Z, Yang X, Xiao S, Zhou Y. MicroRNA-146a affects the chemotherapeutic sensitivity and prognosis of advanced gastric cancer through the regulation of LIN52. Oncol Lett 2017;13:1386-92. [PMID: 28454266 DOI: 10.3892/ol.2016.5536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
154 Mao Y, Chen W, Wu H, Liu C, Zhang J, Chen S. Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma. Onco Targets Ther 2020;13:13479-90. [PMID: 33447052 DOI: 10.2147/OTT.S288791] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
155 Monzon FA, Dumur CI. Diagnosis of uncertain primary tumors with the Pathwork ® tissue-of-origin test. Expert Review of Molecular Diagnostics 2014;10:17-25. [DOI: 10.1586/erm.09.75] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
156 Usó M, Jantus-Lewintre E, Sirera R, Bremnes RM, Camps C. miRNA detection methods and clinical implications in lung cancer. Future Oncol. 2014;10:2279-2292. [PMID: 25471039 DOI: 10.2217/fon.14.93] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
157 Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20:460-469. [PMID: 25027972 DOI: 10.1016/j.molmed.2014.06.005] [Cited by in Crossref: 1125] [Cited by in F6Publishing: 1120] [Article Influence: 140.6] [Reference Citation Analysis]
158 Bohndiek SE, Brindle KM. Imaging and 'omic' methods for the molecular diagnosis of cancer. Expert Rev Mol Diagn 2010;10:417-34. [PMID: 20465497 DOI: 10.1586/erm.10.20] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
159 Wang C, Yang C, Chen X, Yao B, Yang C, Zhu C, Li L, Wang J, Li X, Shao Y, Liu Y, Ji J, Zhang J, Zen K, Zhang C, Zhang C. Altered Profile of Seminal Plasma MicroRNAs in the Molecular Diagnosis of Male Infertility. Clinical Chemistry 2011;57:1722-31. [DOI: 10.1373/clinchem.2011.169714] [Cited by in Crossref: 144] [Cited by in F6Publishing: 139] [Article Influence: 13.1] [Reference Citation Analysis]
160 Lim EL, Trinh DL, Scott DW, Chu A, Krzywinski M, Zhao Y, Robertson AG, Mungall AJ, Schein J, Boyle M, Mottok A, Ennishi D, Johnson NA, Steidl C, Connors JM, Morin RD, Gascoyne RD, Marra MA. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients. Genome Biol 2015;16:18. [PMID: 25723320 DOI: 10.1186/s13059-014-0568-y] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 9.6] [Reference Citation Analysis]
161 Manne U, Shanmugam C, Bovell L, Katkoori VR, Bumpers HL. miRNAs as biomarkers for management of patients with colorectal cancer. Biomark Med 2010;4:761-70. [PMID: 20945991 DOI: 10.2217/bmm.10.87] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
162 Tang W, Wan S, Yang Z, Teschendorff AE, Zou Q. Tumor origin detection with tissue-specific miRNA and DNA methylation markers. Bioinformatics 2018;34:398-406. [PMID: 29028927 DOI: 10.1093/bioinformatics/btx622] [Cited by in Crossref: 140] [Cited by in F6Publishing: 128] [Article Influence: 35.0] [Reference Citation Analysis]
163 Shepshelovich D, Ram R, Uziel O, Kushnir M, Lithwick-yanai G, Hoshen M, Feinmesser M, Bairey O, Lahav M. MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma. Leukemia Research 2015;39:632-7. [DOI: 10.1016/j.leukres.2015.03.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
164 Bruni R, Marcantonio C, Pulsoni A, Tataseo P, De Angelis F, Spada E, Marcucci F, Panfilio S, Bianco P, Riminucci M. microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus. BMC Infect Dis. 2014;14 Suppl 5:S6. [PMID: 25236768 DOI: 10.1186/1471-2334-14-s5-s6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
165 Szelenberger R, Kacprzak M, Saluk-Bijak J, Zielinska M, Bijak M. Plasma MicroRNA as a novel diagnostic. Clin Chim Acta 2019;499:98-107. [PMID: 31499022 DOI: 10.1016/j.cca.2019.09.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
166 Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS Journal 2009;276:2966-82. [DOI: 10.1111/j.1742-4658.2009.07014.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 8.5] [Reference Citation Analysis]
167 Chen S, Lao J, Geng Q, Zhang J, Wu A, Xu D. A 3-MicroRNA Signature Identified From Serum Predicts Clinical Outcome of the Locally Advanced Gastric Cancer. Front Oncol 2020;10:565. [PMID: 32656071 DOI: 10.3389/fonc.2020.00565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
168 Rederstorff M. Une approche originale de sélection de nouveaux ARN non codants. Med Sci (Paris) 2011;27:343-5. [DOI: 10.1051/medsci/2011274003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
169 Varela MA, Roberts TC, Wood MJ. Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy. Neurotherapeutics 2013;10:621-31. [PMID: 24068583 DOI: 10.1007/s13311-013-0212-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
170 van Laar RK, Ma X, de Jong D, Wehkamp D, Floore AN, Warmoes MO, Simon I, Wang W, Erlander M, van't Veer LJ, Glas AM. Implementation of a novel microarray-based diagnostic test for cancer of unknown primary. Int J Cancer 2009;125:1390-7. [DOI: 10.1002/ijc.24504] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
171 Chen WC, Lin MS, Ye YL, Gao HJ, Song ZY, Shen XY. microRNA expression pattern and its alteration following celecoxib intervention in human colorectal cancer. Exp Ther Med. 2012;3:1039-1048. [PMID: 22970014 DOI: 10.3892/etm.2012.531] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
172 Qian L, Winfree E, Bruck J. Neural network computation with DNA strand displacement cascades. Nature 2011;475:368-72. [PMID: 21776082 DOI: 10.1038/nature10262] [Cited by in Crossref: 620] [Cited by in F6Publishing: 405] [Article Influence: 56.4] [Reference Citation Analysis]
173 Hulf T, Sibbritt T, Wiklund ED, Patterson K, Song JZ, Stirzaker C, Qu W, Nair S, Horvath LG, Armstrong NJ, Kench JG, Sutherland RL, Clark SJ. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer. Oncogene 2013;32:2891-9. [PMID: 22869146 DOI: 10.1038/onc.2012.300] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
174 Howlett P, Cleal JK, Wu H, Shah N, Horton A, Curzen N, Mahmoudi M. MicroRNA 8059 as a marker for the presence and extent of coronary artery calcification. Open Heart 2018;5:e000678. [PMID: 29531756 DOI: 10.1136/openhrt-2017-000678] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
175 Ma YY, Tao HQ. Microribonucleic acids and gastric cancer. Cancer Sci. 2012;103:620-625. [PMID: 22168593 DOI: 10.1111/j.1349-7006.2011.02185] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
176 Huertas CS, Fariña D, Lechuga LM. Direct and Label-Free Quantification of Micro-RNA-181a at Attomolar Level in Complex Media Using a Nanophotonic Biosensor. ACS Sens 2016;1:748-56. [DOI: 10.1021/acssensors.6b00162] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
177 Fridman E, Dotan Z, Barshack I, David MB, Dov A, Tabak S, Zion O, Benjamin S, Benjamin H, Kuker H, Avivi C, Rosenblatt K, Polak-Charcon S, Ramon J, Rosenfeld N, Spector Y. Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 2010;12:687-96. [PMID: 20595629 DOI: 10.2353/jmoldx.2010.090187] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
178 Asano N, Matsuzaki J, Ichikawa M, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Yoshida A, Kobayashi E, Tanzawa Y, Nakayama R, Morioka H, Matsumoto M, Nakamura M, Kondo T, Kato K, Tsuchiya N, Kawai A, Ochiya T. A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes. Nat Commun 2019;10:1299. [PMID: 30898996 DOI: 10.1038/s41467-019-09143-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 10.7] [Reference Citation Analysis]
179 Liu HS, Xiao HS. MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol 2014; 20(34): 12007-12017 [PMID: 25232237 DOI: 10.3748/wjg.v20.i34.12007] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
180 Agrawal S, Tapmeier T, Rahmioglu N, Kirtley S, Zondervan K, Becker C. The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review. Int J Mol Sci 2018;19:E599. [PMID: 29463003 DOI: 10.3390/ijms19020599] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
181 Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, Reid G. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One. 2011;6:e24145. [PMID: 21909417 DOI: 10.1371/journal.pone.0024145] [Cited by in Crossref: 336] [Cited by in F6Publishing: 346] [Article Influence: 30.5] [Reference Citation Analysis]
182 Pettit RW, Fullem R, Cheng C, Amos CI. Artificial intelligence, machine learning, and deep learning for clinical outcome prediction. Emerg Top Life Sci 2021:ETLS20210246. [PMID: 34927670 DOI: 10.1042/ETLS20210246] [Reference Citation Analysis]
183 Asadi M, Shanehbandi D, Zafari V, Khaze V, Somi MH, Hashemzadeh S. Transcript Level of MicroRNA Processing Elements in Gastric Cancer. J Gastrointest Cancer 2019;50:855-9. [PMID: 30168106 DOI: 10.1007/s12029-018-0154-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
184 Tao G, Lai T, Xu X, Ma Y, Wu X, Pei X, Liu F, Li N. Colocalized Particle Counting Platform for Zeptomole Level Multiplexed Quantification. Anal Chem 2020;92:3697-706. [PMID: 32037812 DOI: 10.1021/acs.analchem.9b04823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
185 Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol. 2009;27:2030-2037. [PMID: 19273703 DOI: 10.1200/jco.2008.19.4134] [Cited by in Crossref: 284] [Cited by in F6Publishing: 152] [Article Influence: 21.8] [Reference Citation Analysis]
186 Wang Y, Liang Y, Lu Q. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases. Clin Genet 2008;74:307-15. [PMID: 18713257 DOI: 10.1111/j.1399-0004.2008.01075.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
187 Leidinger P, Backes C, Blatt M, Keller A, Huwer H, Lepper P, Bals R, Meese E. The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases. Mol Cancer 2014;13:202. [PMID: 25175044 DOI: 10.1186/1476-4598-13-202] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
188 Salvadores M, Mas-Ponte D, Supek F. Passenger mutations accurately classify human tumors. PLoS Comput Biol 2019;15:e1006953. [PMID: 30986244 DOI: 10.1371/journal.pcbi.1006953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
189 Kuo WT, Su MW, Lee YL, Chen CH, Wu CW, Fang WL, Huang KH, Lin WC. Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets. J Clin Med 2015;4:1798-814. [PMID: 26389959 DOI: 10.3390/jcm4091798] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
190 O’Hara SP, Mott JL, Splinter PL, Gores GJ, LaRusso NF. MicroRNAs: key modulators of posttranscriptional gene expression. Gastroenterology. 2009;136:17-25. [PMID: 19049808 DOI: 10.1053/j.gastro.2008.11.028] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
191 Saito K, Inagaki K, Kamimoto T, Ito Y, Sugita T, Nakajo S, Hirasawa A, Iwamaru A, Ishikura T, Hanaoka H, Okubo K, Onozaki T, Zama T. MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. PLoS One 2013;8:e71480. [PMID: 23967217 DOI: 10.1371/journal.pone.0071480] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
192 Husale S, Persson HH, Sahin O. DNA nanomechanics allows direct digital detection of complementary DNA and microRNA targets. Nature 2009;462:1075-8. [PMID: 20010806 DOI: 10.1038/nature08626] [Cited by in Crossref: 113] [Cited by in F6Publishing: 93] [Article Influence: 8.7] [Reference Citation Analysis]
193 Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, Reid JG, Olokpa E, Itamochi H, Ueno NT, Hawkins SM. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol. 2010;24:447-463. [PMID: 20081105 DOI: 10.1210/me.2009-0295] [Cited by in Crossref: 169] [Cited by in F6Publishing: 163] [Article Influence: 14.1] [Reference Citation Analysis]
194 Monzon FA, Medeiros F, Lyons-Weiler M, Henner WD. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test. Diagn Pathol 2010;5:3. [PMID: 20205775 DOI: 10.1186/1746-1596-5-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
195 Tang Y, Liu M, Xu L, Tian J, Yang X, Zhao Y, Zhao S. A simple and rapid dual-cycle amplification strategy for microRNA based on graphene oxide and exonuclease III-assisted fluorescence recovery. Anal Methods 2018;10:3777-82. [DOI: 10.1039/c8ay01106k] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
196 Takei H, Monzon FA. Gene-expression assays and personalized cancer care: tissue-of-origin test for cancer of unknown primary origin. Personalized Medicine 2011;8:429-36. [DOI: 10.2217/pme.11.37] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
197 Vinci S, Gelmini S, Mancini I, Malentacchi F, Pazzagli M, Beltrami C, Pinzani P, Orlando C. Genetic and epigenetic factors in regulation of microRNA in colorectal cancers. Methods. 2013;59:138-146. [PMID: 22989523 DOI: 10.1016/j.ymeth.2012.09.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
198 Sarver AL. Toward understanding the informatics and statistical aspects of micro-RNA profiling. J Cardiovasc Transl Res 2010;3:204-11. [PMID: 20560041 DOI: 10.1007/s12265-010-9180-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
199 Mueller DW, Bosserhoff A. miRNAs in Malignant Melanoma. In: Bosserhoff A, editor. Melanoma Development. Vienna: Springer; 2011. pp. 105-36. [DOI: 10.1007/978-3-7091-0371-5_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
200 Tang S, Wu WK, Li X, Wong SH, Wong N, Chan MT, Sung JJ, Yu J. Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression. Sci Rep 2016;6:24466. [PMID: 27080237 DOI: 10.1038/srep24466] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
201 Humphries B, Wang Z, Yang C. MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer. Cancers (Basel) 2019;11:E897. [PMID: 31252590 DOI: 10.3390/cancers11070897] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
202 Sereno M, Videira M, Wilhelm I, Krizbai IA, Brito MA. miRNAs in Health and Disease: A Focus on the Breast Cancer Metastatic Cascade towards the Brain. Cells 2020;9:E1790. [PMID: 32731349 DOI: 10.3390/cells9081790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
203 Komori M, Komiya K, Shirakawa T, Morikawa TJ, Yoshimura T. Measurement of microRNA with isothermal DNA amplification on fully automated immunoassay analyzers. Anal Bioanal Chem 2019;411:3789-800. [PMID: 31161320 DOI: 10.1007/s00216-019-01878-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
204 Pavicic W, Perkiö E, Kaur S, Peltomäki P. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach. Mol Med 2011;17:726-35. [PMID: 21327300 DOI: 10.2119/molmed.2010.00239] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
205 Fahy K, Augustine L, Sanden MO, Wassman ER. Clinicians' Real World Perceptions of Pre-Nephrectomy Diagnostic Biopsy Performance as a Driver of Reduction in Unnecessary Surgeries in Renal Tumors. J Kidney Cancer VHL 2015;2:1-14. [PMID: 28326254 DOI: 10.15586/jkcvhl.2015.20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
206 Delpu Y, Larrieu D, Gayral M, Arvanitis D, Dufresne M, Cordelier P, Torrisani J. Noncoding RNAs. Drug Discovery in Cancer Epigenetics. Elsevier; 2016. pp. 305-26. [DOI: 10.1016/b978-0-12-802208-5.00012-6] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
207 Shalgi R, Pilpel Y, Oren M. Repression of transposable-elements - a microRNA anti-cancer defense mechanism? Trends Genet 2010;26:253-9. [PMID: 20417576 DOI: 10.1016/j.tig.2010.03.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
208 Hanson EK, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal Biochem. 2009;387:303-314. [PMID: 19454234 DOI: 10.1016/j.ab.2009.01.037] [Cited by in Crossref: 241] [Cited by in F6Publishing: 213] [Article Influence: 18.5] [Reference Citation Analysis]
209 Braconi C, Roessler S, Kruk B, Lammert F, Krawczyk M, Andersen JB. Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine? Liver Int 2019;39 Suppl 1:32-42. [PMID: 30829432 DOI: 10.1111/liv.14085] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
210 Søkilde R, Vincent M, Møller AK, Hansen A, Høiby PE, Blondal T, Nielsen BS, Daugaard G, Møller S, Litman T. Efficient identification of miRNAs for classification of tumor origin. J Mol Diagn. 2014;16:106-115. [PMID: 24211363 DOI: 10.1016/j.jmoldx.2013.10.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
211 Atri C, Guerfali FZ, Laouini D. MicroRNAs in diagnosis and therapeutics. AGO-Driven Non-Coding RNAs. Elsevier; 2019. pp. 137-77. [DOI: 10.1016/b978-0-12-815669-8.00006-3] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
212 Faber C, Kirchner T, Hlubek F. The impact of microRNAs on colorectal cancer. Virchows Arch. 2009;454:359-367. [PMID: 19288129 DOI: 10.1007/s00428-009-0751-9] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
213 Erlander MG, Ma XJ, Kesty NC, Bao L, Salunga R, Schnabel CA. Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. J Mol Diagn 2011;13:493-503. [PMID: 21708287 DOI: 10.1016/j.jmoldx.2011.04.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
214 Blanco-Calvo M, Calvo L, Figueroa A, Haz-Conde M, Antón-Aparicio L, Valladares-Ayerbes M. Circulating microRNAs: molecular microsensors in gastrointestinal cancer. Sensors (Basel) 2012;12:9349-62. [PMID: 23012546 DOI: 10.3390/s120709349] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
215 Koçana CÇ, Toprak SF, Sözer S. Extracellular genetic materials and their application in clinical practice. Cancer Genet 2021;252-253:48-63. [PMID: 33387935 DOI: 10.1016/j.cancergen.2020.12.006] [Reference Citation Analysis]
216 Iorio MV, Croce CM. Causes and consequences of microRNA dysregulation. Cancer J. 2012;18:215-222. [PMID: 22647357 DOI: 10.1097/ppo.0b013e318250c001] [Cited by in Crossref: 186] [Cited by in F6Publishing: 112] [Article Influence: 18.6] [Reference Citation Analysis]
217 Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 2009;9:401. [PMID: 19922656 DOI: 10.1186/1471-2407-9-401] [Cited by in Crossref: 237] [Cited by in F6Publishing: 220] [Article Influence: 18.2] [Reference Citation Analysis]
218 Hromadnikova I, Kotlabova K, Hympanova L, Krofta L. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood. Thrombosis Research 2016;137:126-40. [DOI: 10.1016/j.thromres.2015.11.032] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 8.7] [Reference Citation Analysis]
219 Van Roosbroeck K, Pollet J, Calin GA. miRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Rev Mol Diagn. 2013;13:183-204. [PMID: 23477558 DOI: 10.1586/erm.12.134] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 9.9] [Reference Citation Analysis]
220 Zhao Y, Shu R, Liu J. The development and improvement of ribonucleic acid therapy strategies. Mol Ther Nucleic Acids 2021;26:997-1013. [PMID: 34540356 DOI: 10.1016/j.omtn.2021.09.002] [Reference Citation Analysis]
221 Spigel DR, Hainsworth JD, Greco FA. Neuroendocrine carcinoma of unknown primary site. Semin Oncol. 2009;36:52-59. [PMID: 19179188 DOI: 10.1053/j.seminoncol.2008.10.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
222 Detassis S, Grasso M, Tabraue-Chávez M, Marín-Romero A, López-Longarela B, Ilyine H, Ress C, Ceriani S, Erspan M, Maglione A, Díaz-Mochón JJ, Pernagallo S, Denti MA. New Platform for the Direct Profiling of microRNAs in Biofluids. Anal Chem 2019;91:5874-80. [PMID: 30994325 DOI: 10.1021/acs.analchem.9b00213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
223 Osaki M, Takeshita F, Ochiya T. MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers. 2008;13:658-670. [PMID: 19096960 DOI: 10.1080/13547500802646572] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 5.7] [Reference Citation Analysis]
224 de Planell-Saguer M, Rodicio MC. Analytical aspects of microRNA in diagnostics: a review. Anal Chim Acta. 2011;699:134-152. [PMID: 21704768 DOI: 10.1016/j.aca.2011.05.025] [Cited by in Crossref: 180] [Cited by in F6Publishing: 167] [Article Influence: 16.4] [Reference Citation Analysis]
225 Hromadnikova I. Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency. DNA Cell Biol 2012;31:1221-32. [PMID: 22364204 DOI: 10.1089/dna.2011.1530] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
226 Kim YK. Extracellular microRNAs as Biomarkers in Human Disease. Chonnam Med J 2015;51:51-7. [PMID: 26306299 DOI: 10.4068/cmj.2015.51.2.51] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
227 Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3:e3148. [PMID: 18773077 DOI: 10.1371/journal.pone.0003148.g001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
228 Eitan R, Kushnir M, Lithwick-yanai G, David MB, Hoshen M, Glezerman M, Hod M, Sabah G, Rosenwald S, Levavi H. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecologic Oncology 2009;114:253-9. [DOI: 10.1016/j.ygyno.2009.04.024] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 8.9] [Reference Citation Analysis]
229 Drakaki A, Iliopoulos D. MicroRNA Gene Networks in Oncogenesis. Curr Genomics 2009;10:35-41. [PMID: 19721809 DOI: 10.2174/138920209787581299] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
230 Stead LF, Berri S, Wood HM, Egan P, Conway C, Daly C, Papagiannopoulos K, Rabbitts P. The transcriptional consequences of somatic amplifications, deletions, and rearrangements in a human lung squamous cell carcinoma. Neoplasia 2012;14:1075-86. [PMID: 23226101 DOI: 10.1593/neo.121380] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
231 Link Y, Romano A, Bejar J, Schiff E, Dotan Y. Widespread osteoblastic metastases and marked elevation of CA19-9 as a presentation of signet ring cell gastric carcinoma. J Gastrointest Oncol 2016;7:E1-5. [PMID: 27034800 DOI: 10.3978/j.issn.2078-6891.2015.086] [Reference Citation Analysis]
232 Hromadnikova I, Kotlabova K, Ondrackova M, Pirkova P, Kestlerova A, Novotna V, Hympanova L, Krofta L. Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications. DNA Cell Biol 2015;34:437-57. [PMID: 25825993 DOI: 10.1089/dna.2014.2687] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 9.7] [Reference Citation Analysis]
233 Raychaudhuri M, Schuster T, Buchner T, Malinowsky K, Bronger H, Schwarz-Boeger U, Höfler H, Avril S. Intratumoral heterogeneity of microRNA expression in breast cancer. J Mol Diagn 2012;14:376-84. [PMID: 22704963 DOI: 10.1016/j.jmoldx.2012.01.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
234 Marquard AM, Birkbak NJ, Thomas CE, Favero F, Krzystanek M, Lefebvre C, Ferté C, Jamal-Hanjani M, Wilson GA, Shafi S, Swanton C, André F, Szallasi Z, Eklund AC. TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen. BMC Med Genomics 2015;8:58. [PMID: 26429708 DOI: 10.1186/s12920-015-0130-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
235 Cao Y, Green K, Quattlebaum S, Milam B, Lu L, Gao D, He H, Li N, Gao L, Hall F, Whinery M, Handley E, Ma Y, Xu T, Jin F, Xiao J, Wei M, Smith D, Bornstein S, Gross N, Pyeon D, Song J, Lu SL. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma. Clin Epigenetics 2018;10:43. [PMID: 29636832 DOI: 10.1186/s13148-018-0470-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
236 Drusco A, Bottoni A, Laganà A, Acunzo M, Fassan M, Cascione L, Antenucci A, Kumchala P, Vicentini C, Gardiman MP, Alder H, Carosi MA, Ammirati M, Gherardi S, Luscrì M, Carapella C, Zanesi N, Croce CM. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies. Oncotarget 2015;6:20829-39. [PMID: 26246487 DOI: 10.18632/oncotarget.4096] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 9.8] [Reference Citation Analysis]
237 Renwick N, Cekan P, Masry PA, McGeary SE, Miller JB, Hafner M, Li Z, Mihailovic A, Morozov P, Brown M, Gogakos T, Mobin MB, Snorrason EL, Feilotter HE, Zhang X, Perlis CS, Wu H, Suárez-Fariñas M, Feng H, Shuda M, Moore PS, Tron VA, Chang Y, Tuschl T. Multicolor microRNA FISH effectively differentiates tumor types. J Clin Invest 2013;123:2694-702. [PMID: 23728175 DOI: 10.1172/JCI68760] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
238 Shen Y, Chu Q, Yin X, He Y, Bai P, Wang Y, Fang W, Timko MP, Fan L, Jiang W. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary. Brief Bioinform 2021;22:2106-18. [PMID: 32266390 DOI: 10.1093/bib/bbaa031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
239 Yang H, Hui A, Pampalakis G, Soleymani L, Liu FF, Sargent EH, Kelley SO. Direct, electronic microRNA detection for the rapid determination of differential expression profiles. Angew Chem Int Ed Engl 2009;48:8461-4. [PMID: 19810065 DOI: 10.1002/anie.200902577] [Cited by in Crossref: 122] [Cited by in F6Publishing: 108] [Article Influence: 10.2] [Reference Citation Analysis]
240 Munker R, Calin GA. MicroRNA profiling in cancer. Clin Sci (Lond). 2011;121:141-158. [PMID: 21526983 DOI: 10.1042/CS20110005] [Cited by in Crossref: 115] [Cited by in F6Publishing: 71] [Article Influence: 10.5] [Reference Citation Analysis]
241 Ahmed EK, Fahmy SA, Effat H, Wahab AHA. Circulating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the Liver. J Med Biochem 2019;38:109-17. [PMID: 30867638 DOI: 10.2478/jomb-2018-0010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
242 Rosenberg E, Baniel J, Spector Y, Faerman A, Meiri E, Aharonov R, Margel D, Goren Y, Nativ O. Predicting progression of bladder urothelial carcinoma using microRNA expression. BJU Int 2013;112:1027-34. [PMID: 23387295 DOI: 10.1111/j.1464-410X.2012.11748.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
243 Mueller DW, Bosserhoff AK. Role of miRNAs in the progression of malignant melanoma. Br J Cancer 2009;101:551-6. [PMID: 19638982 DOI: 10.1038/sj.bjc.6605204] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 6.5] [Reference Citation Analysis]
244 Stancel GA, Coffey D, Alvarez K, Halks-miller M, Lal A, Mody D, Koen T, Fairley T, Monzon FA. Identification of tissue of origin in body fluid specimens using a gene expression microarray assay. Cancer Cytopathology 2012;120:62-70. [DOI: 10.1002/cncy.20167] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
245 Yan N, Wang X, Lin L, Song T, Sun P, Tian H, Liang H, Chen X. Gold Nanorods Electrostatically Binding Nucleic Acid Probe for In Vivo MicroRNA Amplified Detection and Photoacoustic Imaging-Guided Photothermal Therapy. Adv Funct Mater 2018;28:1800490. [DOI: 10.1002/adfm.201800490] [Cited by in Crossref: 61] [Cited by in F6Publishing: 42] [Article Influence: 15.3] [Reference Citation Analysis]
246 Omrane I, Kourda N, Stambouli N, Privat M, Medimegh I, Arfaoui A, Uhrhammer N, Bougatef K, Baroudi O, Bouzaienne H, Marrakchi R, Bignon YJ, Benammar-Elgaaied A. MicroRNAs 146a and 147b biomarkers for colorectal tumor's localization. Biomed Res Int 2014;2014:584852. [PMID: 24800242 DOI: 10.1155/2014/584852] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
247 Malumbres M. miRNAs and cancer: an epigenetics view. Mol Aspects Med. 2013;34:863-874. [PMID: 22771542 DOI: 10.1016/j.mam.2012.06.005] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 9.8] [Reference Citation Analysis]
248 Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27:5848-5856. [PMID: 19884536 DOI: 10.1200/jco.2009.24.0317] [Cited by in Crossref: 690] [Cited by in F6Publishing: 411] [Article Influence: 53.1] [Reference Citation Analysis]
249 Matin F, Jeet V, Clements JA, Yousef GM, Batra J. MicroRNA Theranostics in Prostate Cancer Precision Medicine. Clinical Chemistry 2016;62:1318-33. [DOI: 10.1373/clinchem.2015.242800] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
250 Greco FA. Evolving understanding and current management of patients with cancer of unknown primary site. Community Oncology 2010;7:183-8. [DOI: 10.1016/s1548-5315(11)70301-1] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
251 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
252 Natoli C, Ramazzotti V, Nappi O, Giacomini P, Palmeri S, Salvatore M, Landriscina M, Zilli M, Natali PG, Tinari N, Iacobelli S. Unknown primary tumors. Biochim Biophys Acta 2011;1816:13-24. [PMID: 21371531 DOI: 10.1016/j.bbcan.2011.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
253 Kurokawa K, Tanahashi T, Iima T, Yamamoto Y, Akaike Y, Nishida K, Masuda K, Kuwano Y, Murakami Y, Fukushima M. Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells. J Gastroenterol. 2012;47:883-895. [PMID: 22382630 DOI: 10.1007/s00535-012-0547-6] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
254 Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6:590-610. [PMID: 23102669 DOI: 10.1016/j.molonc.2012.09.006] [Cited by in Crossref: 673] [Cited by in F6Publishing: 659] [Article Influence: 67.3] [Reference Citation Analysis]
255 Cruse G, Metcalfe DD, Olivera A. Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms. Immunol Allergy Clin North Am 2014;34:219-37. [PMID: 24745671 DOI: 10.1016/j.iac.2014.01.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
256 Segersten U, Spector Y, Goren Y, Tabak S, Malmström PU. The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer. Urol Oncol 2014;32:613-8. [PMID: 24439061 DOI: 10.1016/j.urolonc.2013.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
257 Alencar AJ, Malumbres R, Kozloski GA, Advani R, Talreja N, Chinichian S, Briones J, Natkunam Y, Sehn LH, Gascoyne RD, Tibshirani R, Lossos IS. MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin Cancer Res 2011;17:4125-35. [PMID: 21525173 DOI: 10.1158/1078-0432.CCR-11-0224] [Cited by in Crossref: 96] [Cited by in F6Publishing: 53] [Article Influence: 8.7] [Reference Citation Analysis]
258 Tost J, Gut I. Molecular Techniques for DNA Methylation Studies. Molecular Diagnostics. Elsevier; 2017. pp. 103-39. [DOI: 10.1016/b978-0-12-802971-8.00007-9] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
259 Mayer G, Müller J, Lünse CE. RNA diagnostics: real-time RT-PCR strategies and promising novel target RNAs. Wiley Interdiscip Rev RNA 2011;2:32-41. [PMID: 21956968 DOI: 10.1002/wrna.46] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
260 De Paoli P. Institutional shared resources and translational cancer research. J Transl Med 2009;7:54. [PMID: 19563639 DOI: 10.1186/1479-5876-7-54] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
261 Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J, Liu Y, Gao Z, Li J, Shen L. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol. 2011;22:2257-2266. [PMID: 21343377 DOI: 10.1093/annonc/mdq758] [Cited by in Crossref: 112] [Cited by in F6Publishing: 106] [Article Influence: 10.2] [Reference Citation Analysis]
262 Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17:223-238. [PMID: 28233803 DOI: 10.1038/nrc.2017.7] [Cited by in Crossref: 967] [Cited by in F6Publishing: 884] [Article Influence: 193.4] [Reference Citation Analysis]
263 Economopoulou P, Mountzios G, Pavlidis N, Pentheroudakis G. Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer. Cancer Treat Rev 2015;41:598-604. [PMID: 26033502 DOI: 10.1016/j.ctrv.2015.05.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
264 Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Semin Oncol. 2011;38:724-733. [PMID: 22082758 DOI: 10.1053/j.seminoncol.2011.08.006] [Cited by in Crossref: 144] [Cited by in F6Publishing: 145] [Article Influence: 13.1] [Reference Citation Analysis]
265 Westphal M, Lamszus K. Circulating biomarkers for gliomas. Nat Rev Neurol 2015;11:556-66. [PMID: 26369507 DOI: 10.1038/nrneurol.2015.171] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 13.3] [Reference Citation Analysis]
266 Damodaran S, Berger MF, Roychowdhury S. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine. Am Soc Clin Oncol Educ Book. 2015;35:e175-e182. [PMID: 25993170 DOI: 10.14694/edbook_am.2015.35.e175] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
267 Edwards JK, Pasqualini R, Arap W, Calin GA. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J Cardiovasc Transl Res 2010;3:271-9. [PMID: 20560048 DOI: 10.1007/s12265-010-9179-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
268 Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF, Yang MY. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol 2012;33:1933-42. [PMID: 22811001 DOI: 10.1007/s13277-012-0454-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
269 Wu F, Huang D, Wang L, Xu Q, Liu F, Ye X, Meng X, Du X. 92-Gene molecular profiling in identification of cancer origin: a retrospective study in Chinese population and performance within different subgroups. PLoS One 2012;7:e39320. [PMID: 22761762 DOI: 10.1371/journal.pone.0039320] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
270 Egidi MG, Cochetti G, Serva MR, Guelfi G, Zampini D, Mechelli L, Mearini E. Circulating microRNAs and kallikreins before and after radical prostatectomy: are they really prostate cancer markers? Biomed Res Int 2013;2013:241780. [PMID: 24288670 DOI: 10.1155/2013/241780] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
271 Hannouf MB, Winquist E, Mahmud SM, Brackstone M, Sarma S, Rodrigues G, Rogan P, Hoch JS, Zaric GS. Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary. Pharmacogenomics J 2017;17:286-300. [PMID: 27019982 DOI: 10.1038/tpj.2015.94] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
272 Kotlabova K, Doucha J, Hromadnikova I. Placental-specific microRNA in maternal circulation--identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J Reprod Immunol 2011;89:185-91. [PMID: 21513988 DOI: 10.1016/j.jri.2011.02.006] [Cited by in Crossref: 102] [Cited by in F6Publishing: 98] [Article Influence: 9.3] [Reference Citation Analysis]
273 Moniri M, Boroumand Moghaddam A, Azizi S, Abdul Rahim R, Zuhainis Saad W, Navaderi M, Arulselvan P, Mohamad R. Molecular study of wound healing after using biosynthesized BNC/Fe3O4 nanocomposites assisted with a bioinformatics approach. Int J Nanomedicine 2018;13:2955-71. [PMID: 29861630 DOI: 10.2147/IJN.S159637] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
274 Brase JC, Wuttig D, Kuner R, Sültmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer. 2010;9:306. [PMID: 21110877 DOI: 10.1186/1476-4598-9-306;] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
275 Hull ML, Print CG. MicroRNAs in Endometriosis. In: Giudice LC, Evers JLH, Healy DL, editors. Endometriosis. Oxford: Wiley-Blackwell; 2011. pp. 173-83. [DOI: 10.1002/9781444398519.ch17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
276 Tai MC, Yanagisawa K, Nakatochi M, Hotta N, Hosono Y, Kawaguchi K, Naito M, Taniguchi H, Wakai K, Yokoi K, Takahashi T. Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma. Sci Rep 2016;6:31389. [PMID: 27507195 DOI: 10.1038/srep31389] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
277 Lee JC, Zhao JT, Clifton-bligh RJ, Gill AJ, Gundara JS, Ip J, Sywak MS, Delbridge LW, Robinson BG, Sidhu SB. Papillary Thyroid Carcinoma in Pregnancy: A Variant of the Disease? Ann Surg Oncol 2012;19:4210-6. [DOI: 10.1245/s10434-012-2556-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
278 Hirshberg A, Berger R, Allon I, Kaplan I. Metastatic tumors to the jaws and mouth. Head Neck Pathol 2014;8:463-74. [PMID: 25409855 DOI: 10.1007/s12105-014-0591-z] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 8.4] [Reference Citation Analysis]
279 Valbuena GN, Apostolidou S, Roberts R, Barnes J, Alderton W, Harper L, Jacobs I, Menon U, Keun HC. The 14q32 maternally imprinted locus is a major source of longitudinally stable circulating microRNAs as measured by small RNA sequencing. Sci Rep 2019;9:15787. [PMID: 31673048 DOI: 10.1038/s41598-019-51948-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
280 Gilad S, Lithwick-Yanai G, Barshack I, Benjamin S, Krivitsky I, Edmonston TB, Bibbo M, Thurm C, Horowitz L, Huang Y. Classification of the four main types of lung cancer using a microRNA-based diagnostic assay. J Mol Diagn. 2012;14:510-517. [PMID: 22749746 DOI: 10.1016/j.jmoldx.2012.03.004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
281 Gao M, Yin H, Fei ZW. Clinical application of microRNA in gastric cancer in Eastern Asian area. World J Gastroenterol 2013; 19(13): 2019-2027 [PMID: 23599620 DOI: 10.3748/wjg.v19.i13.2019] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
282 Bus P, Kestens C, Ten Kate FJ, Peters W, Drenth JP, Roodhart JM, Siersema PD, van Baal JW. Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol. 2016;51:560-570. [PMID: 26585599 DOI: 10.1007/s00535-015-1133-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
283 Panarelli NC, Chen YT, Zhou XK, Kitabayashi N, Yantiss RK. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma. Pancreas. 2012;41:685-690. [PMID: 22466166 DOI: 10.1097/mpa.0b013e318243a905] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
284 Bonnin N, Armandy E, Carras J, Ferrandon S, Battiston-Montagne P, Aubry M, Guihard S, Meyronet D, Foy JP, Saintigny P, Ledrappier S, Jung A, Rimokh R, Rodriguez-Lafrasse C, Poncet D. MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma. Oncotarget 2016;7:44023-38. [PMID: 27281619 DOI: 10.18632/oncotarget.9829] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
285 Horsham JL, Kalinowski FC, Epis MR, Ganda C, Brown RA, Leedman PJ. Clinical Potential of microRNA-7 in Cancer. J Clin Med 2015;4:1668-87. [PMID: 26308064 DOI: 10.3390/jcm4091668] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
286 Bender RA, Erlander MG. Molecular classification of unknown primary cancer. Semin Oncol 2009;36:38-43. [PMID: 19179186 DOI: 10.1053/j.seminoncol.2008.10.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
287 Liu S, Tetzlaff MT, Liu A, Liegl-Atzwanger B, Guo J, Xu X. Loss of microRNA-205 expression is associated with melanoma progression. Lab Invest 2012;92:1084-96. [PMID: 22525428 DOI: 10.1038/labinvest.2012.62] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
288 Avril S. Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors. Pathologe 2017;38:180-91. [PMID: 29119232 DOI: 10.1007/s00292-017-0375-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
289 Matsuzaki J, Tsugawa H, Suzuki H. Precision Medicine Approaches to Prevent Gastric Cancer. Gut Liver 2021;15:3-12. [PMID: 31893631 DOI: 10.5009/gnl19257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
290 Jiang Q, Feng MG, Mo YY. Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer 2009;9:194. [PMID: 19538740 DOI: 10.1186/1471-2407-9-194] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 5.9] [Reference Citation Analysis]
291 Zubakov D, Boersma AW, Choi Y, van Kuijk PF, Wiemer EA, Kayser M. MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int J Legal Med 2010;124:217-26. [PMID: 20145944 DOI: 10.1007/s00414-009-0402-3] [Cited by in Crossref: 220] [Cited by in F6Publishing: 183] [Article Influence: 18.3] [Reference Citation Analysis]
292 Cheng Q, Han LH, Zhao HJ, Li H, Li JB. Abnormal alterations of miR-1 and miR-214 are associated with clinicopathological features and prognosis of patients with PDAC. Oncol Lett 2017;14:4605-12. [PMID: 29085459 DOI: 10.3892/ol.2017.6819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
293 Hershkovitz-Rokah O, Geva P, Salmon-Divon M, Shpilberg O, Liberman-Aronov S. Network analysis of microRNAs, genes and their regulation in diffuse and follicular B-cell lymphomas. Oncotarget 2018;9:7928-41. [PMID: 29487703 DOI: 10.18632/oncotarget.23974] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
294 Singh P, Soon PS, Feige J, Chabre O, Zhao JT, Cherradi N, Lalli E, Sidhu SB. Dysregulation of microRNAs in adrenocortical tumors. Molecular and Cellular Endocrinology 2012;351:118-28. [DOI: 10.1016/j.mce.2011.09.041] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
295 Han Y, Li J. Sample types applied for molecular diagnosis of therapeutic management of advanced non-small cell lung cancer in the precision medicine. Clinical Chemistry and Laboratory Medicine (CCLM) 2017;55. [DOI: 10.1515/cclm-2017-0112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
296 Sivapragasam M, Rotondo F, Lloyd RV, Scheithauer BW, Cusimano M, Syro LV, Kovacs K. MicroRNAs in the human pituitary. Endocr Pathol 2011;22:134-43. [PMID: 21647843 DOI: 10.1007/s12022-011-9167-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
297 Dong H, Siu H, Luo L, Fang X, Jin L, Xiong M. Investigation gene and microRNA expression in glioblastoma. BMC Genomics 2010;11 Suppl 3:S16. [PMID: 21143783 DOI: 10.1186/1471-2164-11-S3-S16] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
298 Costa FF, Seftor EA, Bischof JM, Kirschmann DA, Strizzi L, Arndt K, Bonaldo Mde F, Soares MB, Hendrix MJ. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics 2009;1:387-98. [PMID: 20495621 DOI: 10.2217/epi.09.25] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
299 Chu LY, Peng YH, Weng XF, Xie JJ, Xu YW. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World J Gastroenterol 2020; 26(15): 1708-1725 [PMID: 32351288 DOI: 10.3748/wjg.v26.i15.1708] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
300 Krämer A, Gattenlöhner S, Neben K. [CUP syndrome: molecular pathogenesis and biology]. Pathologe 2009;30:117-24. [PMID: 19132375 DOI: 10.1007/s00292-008-1114-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
301 Ruepp A, Kowarsch A, Schmidl D, Buggenthin F, Brauner B, Dunger I, Fobo G, Frishman G, Montrone C, Theis FJ. PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biol 2010;11:R6. [PMID: 20089154 DOI: 10.1186/gb-2010-11-1-r6] [Cited by in Crossref: 190] [Cited by in F6Publishing: 169] [Article Influence: 15.8] [Reference Citation Analysis]
302 Masud MK, Na J, Lin T, Malgras V, Preet A, Ibn Sina AA, Wood K, Billah M, Kim J, You J, Kani K, Whitten AE, Salomon C, Nguyen N, Shiddiky MJ, Trau M, Hossain MSA, Yamauchi Y. Nanostructured mesoporous gold biosensor for microRNA detection at attomolar level. Biosensors and Bioelectronics 2020;168:112429. [DOI: 10.1016/j.bios.2020.112429] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
303 Cheng C, Fu X, Alves P, Gerstein M. mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol 2009;10:R90. [PMID: 19723326 DOI: 10.1186/gb-2009-10-9-r90] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 5.8] [Reference Citation Analysis]
304 He M, Zhou W, Li C, Guo M. MicroRNAs, DNA Damage Response, and Cancer Treatment. Int J Mol Sci 2016;17:E2087. [PMID: 27973455 DOI: 10.3390/ijms17122087] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
305 Graybill RM, Bailey RC. Emerging Biosensing Approaches for microRNA Analysis. Anal Chem 2016;88:431-50. [PMID: 26654257 DOI: 10.1021/acs.analchem.5b04679] [Cited by in Crossref: 123] [Cited by in F6Publishing: 105] [Article Influence: 17.6] [Reference Citation Analysis]
306 Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach H, Nietfeld W, Rudel T, Jung K, Kristiansen G. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 2009;13:3918-28. [PMID: 19228262 DOI: 10.1111/j.1582-4934.2009.00705.x] [Cited by in Crossref: 174] [Cited by in F6Publishing: 172] [Article Influence: 13.4] [Reference Citation Analysis]
307 González-Masiá JA, García-Olmo D, García-Olmo DC. Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology. Onco Targets Ther. 2013;6:819-832. [PMID: 23874104 DOI: 10.2147/ott.s44668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
308 Schultz NA, Werner J, Willenbrock H, Roslind A, Giese N, Horn T, Wøjdemann M, Johansen JS. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol. 2012;25:1609-1622. [PMID: 22878649 DOI: 10.1038/modpathol.2012.122] [Cited by in Crossref: 97] [Cited by in F6Publishing: 108] [Article Influence: 9.7] [Reference Citation Analysis]
309 Cho WCS. Omics Approaches in Cancer Research. In: Cho WC, editor. An Omics Perspective on Cancer Research. Dordrecht: Springer Netherlands; 2010. pp. 1-9. [DOI: 10.1007/978-90-481-2675-0_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
310 Chang P, Wang X, Zhou Y, Hou Y. Analysis of the correlation between the expression of miR-655 and esophageal cancer prognosis. Oncol Lett 2017;13:4691-4. [PMID: 28588723 DOI: 10.3892/ol.2017.6047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
311 Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014;64:311-336. [PMID: 25104502 DOI: 10.3322/caac.21244] [Cited by in Crossref: 303] [Cited by in F6Publishing: 301] [Article Influence: 37.9] [Reference Citation Analysis]
312 Anderson BW, Ahlquist DA. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening. Gastroenterol Clin North Am 2016;45:529-42. [PMID: 27546847 DOI: 10.1016/j.gtc.2016.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
313 Parry RM, Jones W, Stokes TH, Phan JH, Moffitt RA, Fang H, Shi L, Oberthuer A, Fischer M, Tong W, Wang MD. k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction. Pharmacogenomics J 2010;10:292-309. [PMID: 20676068 DOI: 10.1038/tpj.2010.56] [Cited by in Crossref: 74] [Cited by in F6Publishing: 49] [Article Influence: 6.2] [Reference Citation Analysis]
314 Perell K, Vincent M, Vainer B, Petersen BL, Federspiel B, Møller AK, Madsen M, Hansen NR, Friis-Hansen L, Nielsen FC, Daugaard G. Development and validation of a microRNA based diagnostic assay for primary tumor site classification of liver core biopsies. Mol Oncol 2015;9:68-77. [PMID: 25131495 DOI: 10.1016/j.molonc.2014.07.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
315 Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 2011;6:482-8. [PMID: 21258252 DOI: 10.1097/JTO.0b013e318208c785] [Cited by in Crossref: 189] [Cited by in F6Publishing: 113] [Article Influence: 17.2] [Reference Citation Analysis]
316 Gerami P, Gammon B, Murphy MJ. Melanocytic Neoplasms I: Molecular Diagnosis. In: Murphy MJ, editor. Molecular Diagnostics in Dermatology and Dermatopathology. Totowa: Humana Press; 2011. pp. 73-103. [DOI: 10.1007/978-1-60761-171-4_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
317 Yendamuri S, Kratzke R. MicroRNA biomarkers in lung cancer: MiRacle or quagMiRe? Transl Res 2011;157:209-15. [PMID: 21420031 DOI: 10.1016/j.trsl.2010.12.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
318 Häusler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, Krockenberger M, Engel JB, Hönig A, Scheffler M. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer. 2010;103:693-700. [PMID: 20683447 DOI: 10.1038/sj.bjc.6605833] [Cited by in Crossref: 139] [Cited by in F6Publishing: 129] [Article Influence: 11.6] [Reference Citation Analysis]
319 Chakraborty C, Das S. Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers. Tumour Biol. 2016;37:5705-5714. [PMID: 26831657 DOI: 10.1007/s13277-016-4907-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 7.2] [Reference Citation Analysis]
320 Marzulli M, Mazzacurati L, Zhang M, Goins WF, Hatley ME, Glorioso JC, Cohen JB. A Novel Oncolytic Herpes Simplex Virus Design based on the Common Overexpression of microRNA-21 in Tumors. J Gene Ther 2018;3. [PMID: 30465046 DOI: 10.13188/2381-3326.1000007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
321 Laprovitera N, Riefolo M, Ambrosini E, Klec C, Pichler M, Ferracin M. Cancer of Unknown Primary: Challenges and Progress in Clinical Management. Cancers (Basel) 2021;13:451. [PMID: 33504059 DOI: 10.3390/cancers13030451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
322 Lu M, Wang C, Yuan Y, Zhu Y, Yin Z, Xia Z, Zhang C. Differentially expressed microRNAs in kidney biopsies from various subtypes of nephrotic children. Exp Mol Pathol 2015;99:590-5. [PMID: 26481277 DOI: 10.1016/j.yexmp.2015.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
323 Huang X, Li J, Lu M, Zhang W, Xu Z, Yu B, Tian J. Point-of-care testing of MicroRNA based on personal glucose meter and dual signal amplification to evaluate drug-induced kidney injury. Analytica Chimica Acta 2020;1112:72-9. [DOI: 10.1016/j.aca.2020.03.051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
324 Greco FA, Erlander MG. Molecular classification of cancers of unknown primary site. Mol Diagn Ther 2009;13:367-73. [PMID: 19925034 DOI: 10.1007/BF03256342] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
325 Cheerla N, Gevaert O. MicroRNA based Pan-Cancer Diagnosis and Treatment Recommendation. BMC Bioinformatics 2017;18:32. [PMID: 28086747 DOI: 10.1186/s12859-016-1421-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
326 Garajová I, Funel N, Fiorentino M, Agostini V, Ferracin M, Negrini M, Frassineti GL, Gavelli G, Frampton AE, Biasco G, Giovannetti E. MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy. Clin Epigenetics 2015;7:129. [PMID: 26677401 DOI: 10.1186/s13148-015-0162-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
327 Acunzo M, Romano G, Wernicke D, Croce CM. MicroRNA and cancer--a brief overview. Adv Biol Regul. 2015;57:1-9. [PMID: 25294678 DOI: 10.1016/j.jbior.2014.09.013] [Cited by in Crossref: 304] [Cited by in F6Publishing: 324] [Article Influence: 38.0] [Reference Citation Analysis]
328 Yan N, Zhang Y, Guo X, Yuan D, Tian G, Yang J. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin. Methods Mol Biol 2020;2204:109-19. [PMID: 32710319 DOI: 10.1007/978-1-0716-0904-0_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
329 Mittelbrunn M, Sánchez-Madrid F. Intercellular communication: diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol 2012;13:328-35. [PMID: 22510790 DOI: 10.1038/nrm3335] [Cited by in Crossref: 354] [Cited by in F6Publishing: 375] [Article Influence: 35.4] [Reference Citation Analysis]
330 Fang Y, Xue J, Shen Q, Chen J, Tian L. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 2012;55:1852-62. [DOI: 10.1002/hep.25576] [Cited by in Crossref: 288] [Cited by in F6Publishing: 280] [Article Influence: 28.8] [Reference Citation Analysis]
331 Xu S, Hazlett LD. MicroRNAs in Ocular Infection. Microorganisms 2019;7:E359. [PMID: 31533211 DOI: 10.3390/microorganisms7090359] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
332 Dancik G, Aisner D, Theodorescu D. A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors. PLoS Curr 2011;3:RRN1248. [PMID: 21858252 DOI: 10.1371/currents.RRN1248] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
333 Ho GY, Jung HJ, Schoen RE, Wang T, Lin J, Williams Z, Weissfeld JL, Park JY, Loudig O, Suh Y. Differential expression of circulating microRNAs according to severity of colorectal neoplasia. Transl Res. 2015;166:225-232. [PMID: 25770825 DOI: 10.1016/j.trsl.2015.02.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
334 Wouters MD, van Gent DC, Hoeijmakers JH, Pothof J. MicroRNAs, the DNA damage response and cancer. Mutat Res. 2011;717:54-66. [PMID: 21477600 DOI: 10.1016/j.mrfmmm.2011.03.012] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
335 Rasnic R, Linial N, Linial M. Enhancing identification of cancer types via lowly-expressed microRNAs. Nucleic Acids Res 2017;45:5048-60. [PMID: 28379430 DOI: 10.1093/nar/gkx210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
336 Qiu X, Hildebrandt N. Rapid and Multiplexed MicroRNA Diagnostic Assay Using Quantum Dot-Based Förster Resonance Energy Transfer. ACS Nano 2015;9:8449-57. [PMID: 26192765 DOI: 10.1021/acsnano.5b03364] [Cited by in Crossref: 175] [Cited by in F6Publishing: 160] [Article Influence: 25.0] [Reference Citation Analysis]
337 Shao T, Wang G, Chen H, Xie Y, Jin X, Bai J, Xu J, Li X, Huang J, Jin Y, Li Y. Survey of miRNA-miRNA cooperative regulation principles across cancer types. Briefings in Bioinformatics 2019;20:1621-38. [DOI: 10.1093/bib/bby038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
338 Greco FA, Spigel DR, Yardley DA, Erlander MG, Ma XJ, Hainsworth JD. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction. Oncologist 2010;15:500-6. [PMID: 20427384 DOI: 10.1634/theoncologist.2009-0328] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 6.7] [Reference Citation Analysis]
339 Lin J, Ma L, Zhang D, Gao J, Jin Y, Han Z, Lin D. Tumour biomarkers-Tracing the molecular function and clinical implication. Cell Prolif 2019;52:e12589. [PMID: 30873683 DOI: 10.1111/cpr.12589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
340 Li Y, Li L, Wang Z, Pan T, Sahni N, Jin X, Wang G, Li J, Zheng X, Zhang Y, Xu J, Yi S, Li X. LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations. Nucleic Acids Res 2018;46:1113-23. [PMID: 29325141 DOI: 10.1093/nar/gkx1311] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 17.3] [Reference Citation Analysis]
341 Xie WQ, Tan SY, Wang XF. Association between miRNA-146a rs2910164 gene polymorphism and susceptibility to colorectal cancer: A systematic review. Shijie Huaren Xiaohua Zazhi 2014; 22(6): 890-897 [DOI: 10.11569/wcjd.v22.i6.890] [Reference Citation Analysis]
342 Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol. 2010;220:126-139. [PMID: 19882673 DOI: 10.1002/path.2638] [Cited by in Crossref: 704] [Cited by in F6Publishing: 653] [Article Influence: 58.7] [Reference Citation Analysis]
343 Huang X, Xu Z, Liu J, Yu B, Tian J. Dual signal amplification for microRNA-21 detection based on duplex-specific nuclease and invertase. RSC Adv 2020;10:11257-62. [DOI: 10.1039/c9ra10657j] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
344 Hasan S, Jacob R, Manne U, Paluri R. Advances in pancreatic cancer biomarkers. Oncol Rev 2019;13:410. [PMID: 31044028 DOI: 10.4081/oncol.2019.410] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
345 Huebner G, Link H, Kohne CH, Stahl M, Kretzschmar A, Steinbach S, Folprecht G, Bernhard H, Al-Batran SE, Schoffski P, Burkart C, Kullmann F, Otremba B, Menges M, Hoffmann M, Kaiser U, Aldaoud A, Jahn A; German CUP Study Group. Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial. Br J Cancer 2009;100:44-9. [PMID: 19066607 DOI: 10.1038/sj.bjc.6604818] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
346 Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, Simi L, Pazzagli M, Orlando C. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med 2011;49:2073-80. [PMID: 21902575 DOI: 10.1515/CCLM.2011.708] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
347 Fu SW, Chen L, Man YG. miRNA Biomarkers in Breast Cancer Detection and Management. J Cancer 2011;2:116-22. [PMID: 21479130 DOI: 10.7150/jca.2.116] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
348 Liu J, Gao J, Du Y, Li Z, Ren Y, Gu J, Wang X, Gong Y, Wang W, Kong X. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer. 2012;131:683-691. [PMID: 21913185 DOI: 10.1002/ijc.26422] [Cited by in Crossref: 171] [Cited by in F6Publishing: 175] [Article Influence: 15.5] [Reference Citation Analysis]
349 Uziel O, Beery E, Dronichev V, Samocha K, Gryaznov S, Weiss L, Slavin S, Kushnir M, Nordenberg Y, Rabinowitz C. Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms. PLoS One. 2010;5:e9132. [PMID: 20161752 DOI: 10.1371/journal.pone.0009132] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
350 Hromadnikova I, Kotlabova K, Dvorakova L, Krofta L. Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications. Int J Cardiol 2019;291:158-67. [PMID: 31151766 DOI: 10.1016/j.ijcard.2019.05.036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
351 Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafà R, Magri E, Lunardi M, Munerato G, Querzoli G, Maestri I. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J Pathol. 2011;225:43-53. [PMID: 21630269 DOI: 10.1002/path.2915] [Cited by in Crossref: 95] [Cited by in F6Publishing: 87] [Article Influence: 8.6] [Reference Citation Analysis]
352 Huang G, Hu H, Xue X, Shen S, Gao E, Guo G, Shen X, Zhang X. Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer. Clin Transl Oncol 2013;15:563-8. [PMID: 23229900 DOI: 10.1007/s12094-012-0966-0] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 8.8] [Reference Citation Analysis]
353 Walsh CJ, Hu P, Batt J, Dos Santos CC. Discovering MicroRNA-Regulatory Modules in Multi-Dimensional Cancer Genomic Data: A Survey of Computational Methods. Cancer Inform 2016;15:25-42. [PMID: 27721651 DOI: 10.4137/CIN.S39369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
354 Yan SY, Chen MM, Li GM, Wang YQ, Fan JG. MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN. Tumour Biol. 2015;36:4747-4755. [PMID: 25647261 DOI: 10.1007/s13277-015-3124-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
355 de Carvalho AC, Scapulatempo-Neto C, Maia DC, Evangelista AF, Morini MA, Carvalho AL, Vettore AL. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma. BMC Med 2015;13:108. [PMID: 25956054 DOI: 10.1186/s12916-015-0350-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
356 Avril S. microRNA-Expression während der Brustentwicklung und in Mammakarzinomen. Pathologe 2013;34:195-200. [DOI: 10.1007/s00292-013-1878-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
357 Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol. 2009;174:1940-1948. [PMID: 19342367 DOI: 10.2353/ajpath.2009.080718] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 8.5] [Reference Citation Analysis]
358 Mueller WC, Spector Y, Edmonston TB, St Cyr B, Jaeger D, Lass U, Aharonov R, Rosenwald S, Chajut A. Accurate classification of metastatic brain tumors using a novel microRNA-based test. Oncologist 2011;16:165-74. [PMID: 21273512 DOI: 10.1634/theoncologist.2010-0305] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
359 Monzon FA, Lyons-Weiler M, Buturovic LJ, Rigl CT, Henner WD, Sciulli C, Dumur CI, Medeiros F, Anderson GG. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin. J Clin Oncol 2009;27:2503-8. [PMID: 19332734 DOI: 10.1200/JCO.2008.17.9762] [Cited by in Crossref: 140] [Cited by in F6Publishing: 55] [Article Influence: 10.8] [Reference Citation Analysis]
360 Deng S, Lang J, Coukos G, Zhang L. Expression profile of microRNA in epithelial cancer: diagnosis, classification and prediction. Expert Opin Med Diagn 2009;3:25-36. [PMID: 23495961 DOI: 10.1517/17530050802651553] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
361 Karthi S, Rajeshwari M, Francis A, Saravanan M, Varalakshmi P, Houlden H, Thangaraj K, Ashokkumar B. 3'-UTR SNP rs2229611 in G6PC1 affects mRNA stability, expression and Glycogen Storage Disease type-Ia risk. Clin Chim Acta 2017;471:46-54. [PMID: 28502559 DOI: 10.1016/j.cca.2017.05.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
362 Mallick R, Patnaik SK, Yendamuri S. MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis. J Carcinog 2010;9:8. [PMID: 20808843 DOI: 10.4103/1477-3163.67074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
363 Tan XG, Zhu J, Cui L. MicroRNA expression signature and target prediction in familial and sporadic primary macronodular adrenal hyperplasia (PMAH). BMC Endocr Disord 2022;22:11. [PMID: 34986816 DOI: 10.1186/s12902-021-00910-7] [Reference Citation Analysis]
364 Maruyama T, Nishihara K, Umikawa M, Arasaki A, Nakasone T, Nimura F, Matayoshi A, Takei K, Nakachi S, Kariya KI, Yoshimi N. MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma. Oncol Lett 2018;15:2349-63. [PMID: 29434944 DOI: 10.3892/ol.2017.7562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
365 Drusco A, Croce CM. MicroRNAs and Cancer: A Long Story for Short RNAs. Adv Cancer Res 2017;135:1-24. [PMID: 28882219 DOI: 10.1016/bs.acr.2017.06.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 11.6] [Reference Citation Analysis]
366 Sereno M, Haskó J, Molnár K, Medina SJ, Reisz Z, Malhó R, Videira M, Tiszlavicz L, Booth SA, Wilhelm I, Krizbai IA, Brito MA. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization. Mol Oncol 2020;14:520-38. [PMID: 31930767 DOI: 10.1002/1878-0261.12632] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
367 Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 2009;9:703-711. [PMID: 19426115 DOI: 10.1517/14712590902932889] [Cited by in Crossref: 299] [Cited by in F6Publishing: 284] [Article Influence: 23.0] [Reference Citation Analysis]
368 Muluhngwi P, Klinge CM. Identification of miRNAs as biomarkers for acquired endocrine resistance in breast cancer. Mol Cell Endocrinol 2017;456:76-86. [PMID: 28163101 DOI: 10.1016/j.mce.2017.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
369 Kandhavelu J, Subramanian K, Khan A, Omar A, Ruff P, Penny C. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression. Microrna 2019;8:68-75. [PMID: 30073936 DOI: 10.2174/2211536607666180803100246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
370 Lee YM, Cho H, Lee SY, Yun SC, Kim JH, Lee SY, Kwon SJ, Choi E, Na MJ, Kang J, Son JW. MicroRNA-23a: A Novel Serum Based Diagnostic Biomarker for Lung Adenocarcinoma. Tuberc Respir Dis 2011;71:8. [DOI: 10.4046/trd.2011.71.1.8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
371 Bhat NS, Colden M, Dar AA, Saini S, Arora P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S, Dahiya R. MicroRNA-720 Regulates E-cadherin-αE-catenin Complex and Promotes Renal Cell Carcinoma. Mol Cancer Ther 2017;16:2840-8. [PMID: 28802251 DOI: 10.1158/1535-7163.MCT-17-0400] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
372 Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Tanaka Y, Chiyomaru T, Deng G, Dahiya R. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res 2013;19:73-84. [PMID: 23147995 DOI: 10.1158/1078-0432.CCR-12-2952] [Cited by in Crossref: 80] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
373 Ojala KA, Kilpinen SK, Kallioniemi OP. Classification of unknown primary tumors with a data-driven method based on a large microarray reference database. Genome Med 2011;3:63. [PMID: 21955394 DOI: 10.1186/gm279] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
374 Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, Kallioniemi OP, Jenster G, Visakorpi T. Androgen regulation of micro-RNAs in prostate cancer. Prostate 2011;71:604-14. [PMID: 20945501 DOI: 10.1002/pros.21276] [Cited by in Crossref: 119] [Cited by in F6Publishing: 109] [Article Influence: 9.9] [Reference Citation Analysis]
375 Hiss D. Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways. J Oncol 2012;2012:737981. [PMID: 22481932 DOI: 10.1155/2012/737981] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
376 Liu X, Chen Z, Yu J, Xia J, Zhou X. MicroRNA profiling and head and neck cancer. Comp Funct Genomics. 2009;837514. [PMID: 19753298 DOI: 10.1155/2009/837514] [Cited by in Crossref: 59] [Cited by in F6Publishing: 86] [Article Influence: 4.5] [Reference Citation Analysis]
377 Kim J, Choi NE, Oh SJ, Park SJ, Kim HK. Combined expression of miR-122a, miR-1, and miR-200b can differentiate degraded RNA samples from liver, pancreas, and stomach. Pathol Int 2011;61:67-72. [PMID: 21255182 DOI: 10.1111/j.1440-1827.2010.02615.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
378 Li B, Ren S, Li X, Wang Y, Garfield D, Zhou S, Chen X, Su C, Chen M, Kuang P. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer. Lung Cancer. 2014;83:146-153. [PMID: 24331411 DOI: 10.1016/j.lungcan.2013.11.003] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 11.2] [Reference Citation Analysis]
379 Torres A, Torres K, Maciejewski R, Harvey WH. MicroRNAs and their role in gynecological tumors. Med Res Rev 2011;31:895-923. [PMID: 20358579 DOI: 10.1002/med.20205] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
380 Bhowmick SS, Saha I, Bhattacharjee D, Genovese LM, Geraci F. Genome-wide analysis of NGS data to compile cancer-specific panels of miRNA biomarkers. PLoS One 2018;13:e0200353. [PMID: 30048452 DOI: 10.1371/journal.pone.0200353] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
381 Deng G, Sui G. Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci 2013;14:18319-49. [PMID: 24013378 DOI: 10.3390/ijms140918319] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 8.3] [Reference Citation Analysis]
382 Zhou Y, Sun YC, Gao KW, Zhu L. Regulatory effect of miR-346/DKK3 axis on tumor cell proliferation in colon cancer. Shijie Huaren Xiaohua Zazhi 2018; 26(34): 1979-1988 [DOI: 10.11569/wcjd.v26.i34.1979] [Reference Citation Analysis]
383 Tost J, Gut IG. Molecular Techniques for DNA Methylation Studies. Molecular Diagnostics. Elsevier; 2010. pp. 199-228. [DOI: 10.1016/b978-0-12-374537-8.00014-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
384 Spadaccino F, Gigante M, Netti GS, Rocchetti MT, Franzin R, Gesualdo L, Castellano G, Stallone G, Ranieri E. The Ambivalent Role of miRNAs in Carcinogenesis: Involvement in Renal Cell Carcinoma and Their Clinical Applications. Pharmaceuticals (Basel) 2021;14:322. [PMID: 33918154 DOI: 10.3390/ph14040322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
385 Panarelli NC, Yantiss RK. MicroRNA Expression in Selected Carcinomas of the Gastrointestinal Tract. Patholog Res Int 2011;2011:124608. [PMID: 21403819 DOI: 10.4061/2011/124608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
386 Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 2009;19:375-383. [PMID: 18624795 DOI: 10.1111/j.1750-3639.2008.00184.x] [Cited by in Crossref: 131] [Cited by in F6Publishing: 128] [Article Influence: 9.4] [Reference Citation Analysis]
387 Gu Y, Shi X, Wang X, Liu X, Xie Y. Expression profile of miRNA in NSCLC tissues in middle-altitude area. Oncol Lett 2020;19:783-94. [PMID: 31897195 DOI: 10.3892/ol.2019.11176] [Reference Citation Analysis]
388 Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene. 2012;31:1609-1622. [PMID: 21860412 DOI: 10.1038/onc.2011.354] [Cited by in Crossref: 243] [Cited by in F6Publishing: 234] [Article Influence: 22.1] [Reference Citation Analysis]
389 Danielson LS, Menendez S, Attolini CS, Guijarro MV, Bisogna M, Wei J, Socci ND, Levine DA, Michor F, Hernando E. A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy. Am J Pathol 2010;177:908-17. [PMID: 20558575 DOI: 10.2353/ajpath.2010.091150] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
390 Bhattacharjya S, Nath S, Ghose J, Maiti GP, Biswas N, Bandyopadhyay S, Panda CK, Bhattacharyya NP, Roychoudhury S. miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression. Cell Death Differ 2013;20:430-42. [PMID: 23099851 DOI: 10.1038/cdd.2012.135] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
391 Centeno BA, Bloom G, Chen DT, Chen Z, Gruidl M, Nasir A, Yeatman TY. Hybrid model integrating immunohistochemistry and expression profiling for the classification of carcinomas of unknown primary site. J Mol Diagn 2010;12:476-86. [PMID: 20558571 DOI: 10.2353/jmoldx.2010.090197] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
392 Turanli B, Yildirim E, Gulfidan G, Arga KY, Sinha R. Current State of "Omics" Biomarkers in Pancreatic Cancer. J Pers Med 2021;11:127. [PMID: 33672926 DOI: 10.3390/jpm11020127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
393 Galoian K, Guettouche T, Issac B, Navarro L, Temple HT. Lost miRNA surveillance of Notch, IGFR pathway—road to sarcomagenesis. Tumor Biol 2014;35:483-92. [DOI: 10.1007/s13277-013-1068-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
394 Park JW, Jeong JM, Cho KS, Cho SY, Cheon JH, Choi DH, Park SJ, Kim HK. MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases. PLoS One 2021;16:e0250083. [PMID: 33852640 DOI: 10.1371/journal.pone.0250083] [Reference Citation Analysis]
395 Ichinose J, Shinozaki-Ushiku A, Takai D, Fukayama M, Nakajima J. Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 2016;16:403-10. [PMID: 26813704 DOI: 10.1586/14737140.2016.1147352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
396 Wei J, Liu B, Cardona AF, Rosell R. Molecular biomarkers for predicting chemotherapy response in lung cancer. Expert Opin Med Diagn 2009;3:621-9. [PMID: 23496047 DOI: 10.1517/17530050903222239] [Reference Citation Analysis]
397 Stella GM, Senetta R, Cassenti A, Ronco M, Cassoni P. Cancers of unknown primary origin: current perspectives and future therapeutic strategies. J Transl Med 2012;10:12. [PMID: 22272606 DOI: 10.1186/1479-5876-10-12] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
398 Pinto Y, Buchumenski I, Levanon EY, Eisenberg E. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets. Nucleic Acids Res 2018;46:71-82. [PMID: 29165639 DOI: 10.1093/nar/gkx1176] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 13.3] [Reference Citation Analysis]
399 Drusco A, Nuovo GJ, Zanesi N, Di Leva G, Pichiorri F, Volinia S, Fernandez C, Antenucci A, Costinean S, Bottoni A. MicroRNA profiles discriminate among colon cancer metastasis. PLoS One. 2014;9:e96670. [PMID: 24921248 DOI: 10.1371/journal.pone.0096670] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 10.1] [Reference Citation Analysis]
400 Green D, Mohorianu I, Piec I, Turner J, Beadsmoore C, Toms A, Ball R, Nolan J, McNamara I, Dalmay T, Fraser WD. MicroRNA expression in a phosphaturic mesenchymal tumour. Bone Rep 2017;7:63-9. [PMID: 28932769 DOI: 10.1016/j.bonr.2017.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
401 Xing F, Watabe K. miRNAs as biomarkers for brain metastasis of breast cancer. Biomark Med 2013;7:387-90. [PMID: 23734799 DOI: 10.2217/bmm.13.43] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
402 Kang SM, Lee HJ. MicroRNAs in human lung cancer. Exp Biol Med (Maywood) 2014;239:1505-13. [PMID: 24872439 DOI: 10.1177/1535370214533887] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
403 Wang Y, Ji J, Weng H, Wang B, Wang F. MiR-139 in digestive system tumor diagnosis and detection: Bioinformatics and meta-analysis. Clinica Chimica Acta 2018;485:33-41. [DOI: 10.1016/j.cca.2018.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
404 Kichukova TM, Popov NT, Ivanov HY, Vachev TI. Circulating microRNAs as a Novel Class of Potential Diagnostic Biomarkers in Neuropsychiatric Disorders. Folia Medica 2016;57:159-72. [DOI: 10.1515/folmed-2015-0035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
405 Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4:143-159. [PMID: 22351564 DOI: 10.1002/emmm.201100209] [Cited by in Crossref: 1001] [Cited by in F6Publishing: 942] [Article Influence: 100.1] [Reference Citation Analysis]
406 Kunz M, Göttlich C, Walles T, Nietzer S, Dandekar G, Dandekar T. MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact. Tumour Biol 2017;39:101042831770643. [DOI: 10.1177/1010428317706430] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
407 Tzur G, Israel A, Levy A, Benjamin H, Meiri E, Shufaro Y, Meir K, Khvalevsky E, Spector Y, Rojansky N, Bentwich Z, Reubinoff BE, Galun E. Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development. PLoS One 2009;4:e7511. [PMID: 19841744 DOI: 10.1371/journal.pone.0007511] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 6.4] [Reference Citation Analysis]
408 Vignier N, Amor F, Fogel P, Duvallet A, Poupiot J, Charrier S, Arock M, Montus M, Nelson I, Richard I, Carrier L, Servais L, Voit T, Bonne G, Israeli D. Distinctive serum miRNA profile in mouse models of striated muscular pathologies. PLoS One 2013;8:e55281. [PMID: 23418438 DOI: 10.1371/journal.pone.0055281] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 7.7] [Reference Citation Analysis]
409 Leibowitz-amit R, Sidi Y, Avni D. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma. Pigment Cell Melanoma Res 2012;25:740-57. [DOI: 10.1111/pcmr.12018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
410 Li X, Zheng F, Ren R. Detecting miRNA by producing RNA: a sensitive assay that combines rolling-circle DNA polymerization and rolling circle transcription. Chem Commun (Camb) 2015;51:11976-9. [PMID: 26120604 DOI: 10.1039/c5cc01748c] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Article Influence: 3.8] [Reference Citation Analysis]
411 Smith SM, Murray DW. An overview of microRNA methods: expression profiling and target identification. Methods Mol Biol 2012;823:119-38. [PMID: 22081343 DOI: 10.1007/978-1-60327-216-2_9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
412 Lu D, Davis MP, Abreu-Goodger C, Wang W, Campos LS, Siede J, Vigorito E, Skarnes WC, Dunham I, Enright AJ, Liu P. MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs. PLoS One 2012;7:e40938. [PMID: 22912667 DOI: 10.1371/journal.pone.0040938] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
413 Chiang WM, Kapadia M, Laver NV, Nystrom JS. Cancer of Unknown Primary: From Immunohistochemistry to Gene Expression Profiling. JCO 2012;30:e300-2. [DOI: 10.1200/jco.2011.41.1827] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
414 Li Z, Qin T, Wang K, Hackenberg M, Yan J, Gao Y, Yu LR, Shi L, Su Z, Chen T. Integrated microRNA, mRNA, and protein expression profiling reveals microRNA regulatory networks in rat kidney treated with a carcinogenic dose of aristolochic acid. BMC Genomics 2015;16:365. [PMID: 25952319 DOI: 10.1186/s12864-015-1516-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
415 Lajer CB, Garnæs E, Friis-Hansen L, Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D, Skotte L, Specht L, Buchwald C, Nielsen FC. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer 2012;106:1526-34. [PMID: 22472886 DOI: 10.1038/bjc.2012.109] [Cited by in Crossref: 148] [Cited by in F6Publishing: 136] [Article Influence: 14.8] [Reference Citation Analysis]
416 Dang Z, Xu WH, Lu P, Wu N, Liu J, Ruan B, Zhou L, Song WJ, Dou KF. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma. Int J Biol Sci 2014;10:733-45. [PMID: 25013381 DOI: 10.7150/ijbs.8097] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
417 Van Seuningen I, Vincent A. Mucins: a new family of epigenetic biomarkers in epithelial cancers. Expert Opin Med Diagn 2009;3:411-27. [PMID: 23485209 DOI: 10.1517/17530050902852697] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
418 Perakis SO, Thomas JE, Pichler M. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients. Adv Exp Med Biol 2016;937:183-204. [PMID: 27573901 DOI: 10.1007/978-3-319-42059-2_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
419 Zeng J, Yi X, Liu H, Yang Y, Duan Y, Chen H. Polymorphisms in four microRNAs and risk of oral squamous cell cancer: a meta-analysis. Oncotarget 2018;9:8695-705. [PMID: 29492228 DOI: 10.18632/oncotarget.24211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
420 Ram H, Kumar M, Bhatt ML, Shadab M. Oral metastases from carcinoma of cervix. BMJ Case Rep 2013;2013:bcr2013010020. [PMID: 23771978 DOI: 10.1136/bcr-2013-010020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
421 Hao Y, Zhao Y, Zhao X, He C, Pang X, Wu TC, Califano JA, Gu X. Improvement of prostate cancer detection by integrating the PSA test with miRNA expression profiling. Cancer Invest 2011;29:318-24. [PMID: 21345070 DOI: 10.3109/07357907.2011.554477] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
422 Inada K, Okoshi Y, Cho-Isoda Y, Ishiguro S, Suzuki H, Oki A, Tamaki Y, Shimazui T, Saito H, Hori M, Iijima T, Kojima H. Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissue. Sci Rep 2018;8:5918. [PMID: 29651113 DOI: 10.1038/s41598-018-24338-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
423 Cheng L, Ling ZQ, Mao WM. MicroRNAs and esophageal cancer. Shijie Huaren Xiaohua Zazhi 2010; 18(23): 2434-2441 [DOI: 10.11569/wcjd.v18.i23.2434] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
424 Vescovo VD, Grasso M, Barbareschi M, Denti MA. MicroRNAs as lung cancer biomarkers. World J Clin Oncol 2014; 5(4): 604-620 [PMID: 25302165 DOI: 10.5306/wjco.v5.i4.604] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
425 Palmieri A, Carinci F, Martinelli M, Pezzetti F, Girardi A, Cura F, Rubini C, Scapoli L. Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma. Eur J Oral Sci 2014;122:198-201. [PMID: 24612133 DOI: 10.1111/eos.12121] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
426 Cascione L, Ferro A, Giugno R, Laganà A, Pigola G, Pulvirenti A, Veneziano D. Elucidating the Role of microRNAs in Cancer Through Data Mining Techniques. In: Schmitz U, Wolkenhauer O, Vera J, editors. MicroRNA Cancer Regulation. Dordrecht: Springer Netherlands; 2013. pp. 291-315. [DOI: 10.1007/978-94-007-5590-1_15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
427 Inoue N, Isomoto H, Matsushima K, Hayashi T, Kunizaki M, Hidaka S, Machida H, Mitsutake N, Nanashima A, Takeshima F, Nakayama T, Ohtsuru A, Nakashima M, Nagayasu T, Yamashita S, Nakao K, Kohno S. Down-regulation of microRNA 10a expression in esophageal squamous cell carcinoma cells. Oncol Lett 2010;1:527-31. [PMID: 22966337 DOI: 10.3892/ol_00000093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
428 Rehman O, Zhuang H, Muhamed Ali A, Ibrahim A, Li Z. Validation of miRNAs as Breast Cancer Biomarkers with a Machine Learning Approach. Cancers (Basel). 2019;11:431. [PMID: 30917548 DOI: 10.3390/cancers11030431] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
429 Rossi S, Kopetz S, Davuluri R, Hamilton SR, Calin GA. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol. 2010;42:1291-1297. [PMID: 19497386 DOI: 10.1016/j.biocel.2009.05.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
430 Greco FA. Cancer of unknown primary site: improved patient management with molecular and immunohistochemical diagnosis. Am Soc Clin Oncol Educ Book 2013;:175-81. [PMID: 23714493 DOI: 10.14694/EdBook_AM.2013.33.175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
431 Jia G, Wang X, Li Q, Lu W, Tang X, Wistuba I, Xie Y. RCRnorm: An integrated system of random-coefficient hierarchical regression models for normalizing NanoString nCounter data. Ann Appl Stat 2019;13:1617-47. [PMID: 33564347 DOI: 10.1214/19-aoas1249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
432 Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, Ganesan S, Levine AJ, Rathmell WK, Bhanot GV. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst Biol 2010;4:51. [PMID: 20420713 DOI: 10.1186/1752-0509-4-51] [Cited by in Crossref: 184] [Cited by in F6Publishing: 176] [Article Influence: 15.3] [Reference Citation Analysis]
433 Bhat K, Wang F, Ma Q, Li Q, Mallik S, Hsieh TC, Wu E. Advances in biomarker research for pancreatic cancer. Curr Pharm Des 2012;18:2439-51. [PMID: 22372502 DOI: 10.2174/13816128112092439] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
434 Dedeoğlu BG. High-throughput approaches for microRNA expression analysis. Methods Mol Biol 2014;1107:91-103. [PMID: 24272433 DOI: 10.1007/978-1-62703-748-8_6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
435 Lombardo R, Tosi F, Nocerino A, Bencardino K, Gambi V, Ricotta R, Spina F, Siena S, Sartore-Bianchi A. The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review. Front Oncol 2020;10:533. [PMID: 32457826 DOI: 10.3389/fonc.2020.00533] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
436 Gamazon ER, Innocenti F, Wei R, Wang L, Zhang M, Mirkov S, Ramírez J, Huang RS, Cox NJ, Ratain MJ, Liu W. A genome-wide integrative study of microRNAs in human liver. BMC Genomics 2013;14:395. [PMID: 23758991 DOI: 10.1186/1471-2164-14-395] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
437 Pöhlmann C, Sprinzl M. Electrochemical Detection of MicroRNAs via Gap Hybridization Assay. Anal Chem 2010;82:4434-40. [DOI: 10.1021/ac100186p] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 8.3] [Reference Citation Analysis]
438 Wang H, Jiang Y, Peng H, Chen Y, Zhu P, Huang Y. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors. Advanced Drug Delivery Reviews 2015;81:142-60. [DOI: 10.1016/j.addr.2014.10.031] [Cited by in Crossref: 145] [Cited by in F6Publishing: 135] [Article Influence: 20.7] [Reference Citation Analysis]
439 Baranauskas JA. The number of classes as a source for instability of decision tree algorithms in high dimensional datasets. Artif Intell Rev 2015;43:301-10. [DOI: 10.1007/s10462-012-9374-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
440 Giusti I, D'Ascenzo S, Dolo V. Microvesicles as potential ovarian cancer biomarkers. Biomed Res Int 2013;2013:703048. [PMID: 23484144 DOI: 10.1155/2013/703048] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
441 Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009;9:293-302. [PMID: 19262572 DOI: 10.1038/nrc2619] [Cited by in Crossref: 567] [Cited by in F6Publishing: 542] [Article Influence: 43.6] [Reference Citation Analysis]
442 Buhagiar A, Borg J, Ayers D. Overview of current microRNA biomarker signatures as potential diagnostic tools for leukaemic conditions. Noncoding RNA Res 2020;5:22-6. [PMID: 32110743 DOI: 10.1016/j.ncrna.2020.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
443 García-Giménez JL, Seco-Cervera M, Tollefsbol TO, Romá-Mateo C, Peiró-Chova L, Lapunzina P, Pallardó FV. Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory. Crit Rev Clin Lab Sci 2017;54:529-50. [PMID: 29226748 DOI: 10.1080/10408363.2017.1410520] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
444 Graybill RM, Para CS, Bailey RC. PCR-Free, Multiplexed Expression Profiling of microRNAs Using Silicon Photonic Microring Resonators. Anal Chem 2016;88:10347-51. [PMID: 27726377 DOI: 10.1021/acs.analchem.6b03350] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
445 Guo S, Liu M, Gonzalez-Perez RR. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta. 2011;1815:197-213. [PMID: 21193018 DOI: 10.1016/j.bbcan.2010.12.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 116] [Article Influence: 3.9] [Reference Citation Analysis]
446 Fanini F, Vannini I, Amadori D, Fabbri M. Clinical implications of microRNAs in lung cancer. Semin Oncol 2011;38:776-80. [PMID: 22082763 DOI: 10.1053/j.seminoncol.2011.08.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
447 Melo SA, Kalluri R. Molecular pathways: microRNAs as cancer therapeutics. Clin Cancer Res. 2012;18:4234-4239. [PMID: 22711704 DOI: 10.1158/1078-0432.ccr-11-2010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
448 Visone R, Croce CM. MiRNAs and cancer. Am J Pathol 2009;174:1131-8. [PMID: 19264914 DOI: 10.2353/ajpath.2009.080794] [Cited by in Crossref: 271] [Cited by in F6Publishing: 260] [Article Influence: 20.8] [Reference Citation Analysis]
449 Karmon AE, Cardozo ER, Rueda BR, Styer AK. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention? Hum Reprod Update. 2014;20:670-687. [PMID: 24706045 DOI: 10.1093/humupd/dmu017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
450 Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K. Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site. J Clin Oncol. 2019;37:570-579. [PMID: 30653423 DOI: 10.1200/jco.18.00771] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 14.7] [Reference Citation Analysis]
451 Verduin M, Compter I, Steijvers D, Postma AA, Eekers DBP, Anten MM, Ackermans L, Ter Laan M, Leijenaar RTH, van de Weijer T, Tjan-Heijnen VCG, Hoeben A, Vooijs M. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response. Dis Markers 2018;2018:2908609. [PMID: 29581794 DOI: 10.1155/2018/2908609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
452 Shah P, Choi SW, Kim HJ, Cho SK, Thulstrup PW, Bjerrum MJ, Bhang YJ, Ahn JC, Yang SW. DNA/RNA chimera templates improve the emission intensity and target the accessibility of silver nanocluster-based sensors for human microRNA detection. Analyst 2015;140:3422-30. [PMID: 25759134 DOI: 10.1039/c5an00093a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 2.9] [Reference Citation Analysis]
453 Bockmayr T, Erdmann G, Treue D, Jurmeister P, Schneider J, Arndt A, Heim D, Bockmayr M, Sachse C, Klauschen F. Multiclass cancer classification in fresh frozen and formalin-fixed paraffin-embedded tissue by DigiWest multiplex protein analysis. Lab Invest 2020;100:1288-99. [PMID: 32601356 DOI: 10.1038/s41374-020-0455-y] [Reference Citation Analysis]
454 Yang M, Yao Y, Eades G, Zhang Y, Zhou Q. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res Treat 2011;129:983-91. [PMID: 21638050 DOI: 10.1007/s10549-011-1604-1] [Cited by in Crossref: 158] [Cited by in F6Publishing: 154] [Article Influence: 14.4] [Reference Citation Analysis]
455 Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu Y, Li J, Hasina R, Cheng C, Lingen MW, Gerstein MB, Weichselbaum RR, Xing HR, Lussier YA. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol 2010;6:e1000730. [PMID: 20369013 DOI: 10.1371/journal.pcbi.1000730] [Cited by in Crossref: 115] [Cited by in F6Publishing: 108] [Article Influence: 9.6] [Reference Citation Analysis]
456 Sahranavardfard P, Madjd Z, Emami Razavi AN, Ghanadan AR, Firouzi J, Khosravani P, Ghavami S, Ebrahimie E, Ebrahimi M. An Integrative Analysis of The Micro-RNAs Contributing in Stemness, Metastasis and B-Raf Pathways in Malignant Melanoma and Melanoma Stem Cell. Cell J 2021;23:261-72. [PMID: 34308569 DOI: 10.22074/cellj.2021.7311] [Reference Citation Analysis]
457 Scaravilli M, Kivinummi K, Visakorpi T, Latonen L. Measuring the Expression of microRNAs Regulated by Androgens. Methods Mol Biol 2016;1443:151-63. [PMID: 27246339 DOI: 10.1007/978-1-4939-3724-0_10] [Reference Citation Analysis]
458 Pentheroudakis G, Pavlidis N, Fountzilas G, Krikelis D, Goussia A, Stoyianni A, Sanden M, St Cyr B, Yerushalmi N, Benjamin H. Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary. Mol Cancer. 2013;12:57. [PMID: 23758919 DOI: 10.1186/1476-4598-12-57] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
459 Guo S, Xu X, Tang Y, Zhang C, Li J, Ouyang Y, Ju J, Bie P, Wang H. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Cancer Letters 2014;344:40-6. [DOI: 10.1016/j.canlet.2013.10.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
460 Cowan ML, Vandenbussche CJ. Cancer of unknown primary: Ancillary testing of cytologic and small biopsy specimens in the era of targeted therapy. Cancer Cytopathology 2018;126:724-37. [DOI: 10.1002/cncy.22014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
461 Endo K, Hayashi K, Saito H. High-resolution Identification and Separation of Living Cell Types by Multiple microRNA-responsive Synthetic mRNAs. Sci Rep 2016;6:21991. [PMID: 26902536 DOI: 10.1038/srep21991] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
462 Laprovitera N, Grzes M, Porcellini E, Ferracin M. Cancer Site-Specific Multiple microRNA Quantification by Droplet Digital PCR. Front Oncol 2018;8:447. [PMID: 30374423 DOI: 10.3389/fonc.2018.00447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
463 Sequeira-Lopez ML, Weatherford ET, Borges GR, Monteagudo MC, Pentz ES, Harfe BD, Carretero O, Sigmund CD, Gomez RA. The microRNA-processing enzyme dicer maintains juxtaglomerular cells. J Am Soc Nephrol. 2010;21:460-467. [PMID: 20056748 DOI: 10.1681/asn.2009090964] [Cited by in Crossref: 115] [Cited by in F6Publishing: 80] [Article Influence: 9.6] [Reference Citation Analysis]
464 Dumur CI, Fuller CE, Blevins TL, Schaum JC, Wilkinson DS, Garrett CT, Powers CN. Clinical Verification of the Performance of the Pathwork Tissue of Origin Test. American Journal of Clinical Pathology 2011;136:924-33. [DOI: 10.1309/ajcpdqpfo73ssnfr] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
465 Raber MN. Carcinoma of unknown primary origin: on the cusp of a new era. Cancer J 2010;16:66-7. [PMID: 20164693 DOI: 10.1097/PPO.0b013e3181ce4769] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
466 Jeanteur P. miARNs et cancer. Bulletin du Cancer 2010;97:1231-9. [DOI: 10.1684/bdc.2010.1201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
467 Wang Y, Chen M, Tao Z, Hua Q, Chen S, Xiao B. Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data. Cancer Genet 2013;206:340-6. [PMID: 24238754 DOI: 10.1016/j.cancergen.2013.09.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
468 Shivapurkar N, Weiner LM, Marshall JL, Madhavan S, Deslattes Mays A, Juhl H, Wellstein A. Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs. PLoS One. 2014;9:e84686. [PMID: 24400111 DOI: 10.1371/journal.pone.0084686] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
469 Wu Y, Li Z, Shi M, Yuan K, Meng HM, Qu L, Li Z. Programmable DNAzyme Computing for Specific In Vivo Imaging: Intracellular Stimulus-Unlocked Target Sensing and Signal Amplification. Anal Chem 2021;93:12456-63. [PMID: 34449199 DOI: 10.1021/acs.analchem.1c02699] [Reference Citation Analysis]
470 Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012;482:347-355. [PMID: 22337054 DOI: 10.1038/nature10888] [Cited by in Crossref: 742] [Cited by in F6Publishing: 722] [Article Influence: 74.2] [Reference Citation Analysis]
471 Li H, Shang H, Shu D, Zhang H, Ji J, Sun B, Li H, Xie Q. gga-miR-375 plays a key role in tumorigenesis post subgroup J avian leukosis virus infection. PLoS One 2014;9:e90878. [PMID: 24694742 DOI: 10.1371/journal.pone.0090878] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
472 Löffler H, Neben K, Krämer A. [Structured diagnostics and therapy of the CUP syndrome]. Radiologe 2014;54:112-6. [PMID: 24435157 DOI: 10.1007/s00117-013-2545-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
473 Abu-halima M, Backes C, Leidinger P, Keller A, Lubbad AM, Hammadeh M, Meese E. MicroRNA expression profiles in human testicular tissues of infertile men with different histopathologic patterns. Fertility and Sterility 2014;101:78-86.e2. [DOI: 10.1016/j.fertnstert.2013.09.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 8.9] [Reference Citation Analysis]
474 Neben K, Hübner G, Folprecht G, Jäger D, Krämer A. Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome. Dtsch Arztebl Int 2008;105:733-40. [PMID: 19623297 DOI: 10.3238/arztebl.2008.0733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
475 Petrocca F, Lieberman J. Promise and Challenge of RNA Interference–Based Therapy for Cancer. JCO 2011;29:747-54. [DOI: 10.1200/jco.2009.27.6287] [Cited by in Crossref: 87] [Cited by in F6Publishing: 41] [Article Influence: 7.9] [Reference Citation Analysis]
476 Eikmans M, Rekers NV, Anholts JD, Heidt S, Claas FH. Blood cell mRNAs and microRNAs: optimized protocols for extraction and preservation. Blood 2013;121:e81-9. [PMID: 23327925 DOI: 10.1182/blood-2012-06-438887] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
477 Wu Z, Zhou H, He J, Li M, Ma X, Xue J, Li X, Fan X. G-triplex based molecular beacon with duplex-specific nuclease amplification for the specific detection of microRNA. Analyst 2019;144:5201-6. [DOI: 10.1039/c9an01075k] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
478 Sherafatian M, Arjmand F. Decision tree-based classifiers for lung cancer diagnosis and subtyping using TCGA miRNA expression data. Oncol Lett 2019;18:2125-31. [PMID: 31423286 DOI: 10.3892/ol.2019.10462] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
479 Xu Q, Chen J, Ni S, Tan C, Xu M, Dong L, Yuan L, Wang Q, Du X. Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin. Mod Pathol 2016;29:546-56. [PMID: 26990976 DOI: 10.1038/modpathol.2016.60] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
480 Xu L, Tang W. Associations of Polymorphisms in mir-196a2, mir-146a and mir-149 with Colorectal Cancer Risk: A Meta-Analysis. Pathol Oncol Res. 2016;22:261-267. [PMID: 26208586 DOI: 10.1007/s12253-014-9843-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
481 Makondi PT, Wei PL, Huang CY, Chang YJ. Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach. PLoS One 2019;14:e0211968. [PMID: 30807603 DOI: 10.1371/journal.pone.0211968] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
482 Dawood S. Novel biomarkers of metastatic cancer. Expert Rev Mol Diagn 2010;10:581-90. [PMID: 20629508 DOI: 10.1586/erm.10.35] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
483 Russo F, Scoyni F, Fatica A, Pellegrini M, Ferro A, Pulvirenti A, Giugno R. Circulating Noncoding RNAs as Clinical Biomarkers. Epigenetic Biomarkers and Diagnostics. Elsevier; 2016. pp. 239-58. [DOI: 10.1016/b978-0-12-801899-6.00012-7] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
484 Bogner PN, Patnaik SK, Pitoniak R, Kannisto E, Repasky E, Hylander B, Yendamuri S, Ramnath N. Lung cancer xenografting alters microRNA profile but not immunophenotype. Biochem Biophys Res Commun 2009;386:305-10. [PMID: 19523437 DOI: 10.1016/j.bbrc.2009.06.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
485 Tam W. The emergent role of microRNAs in molecular diagnostics of cancer. J Mol Diagn 2008;10:411-4. [PMID: 18687791 DOI: 10.2353/jmoldx.2008.080067] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
486 Diab M, Muqbil I, Mohammad RM, Azmi AS, Philip PA. The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma. J Clin Med 2016;5:E59. [PMID: 27322337 DOI: 10.3390/jcm5060059] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
487 Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136:586-591. [PMID: 19239879 DOI: 10.1016/j.cell.2009.02.005] [Cited by in Crossref: 636] [Cited by in F6Publishing: 638] [Article Influence: 48.9] [Reference Citation Analysis]
488 Guttery DS, Blighe K, Page K, Marchese SD, Hills A, Coombes RC, Stebbing J, Shaw JA. Hide and seek: tell-tale signs of breast cancer lurking in the blood. Cancer Metastasis Rev 2013;32:289-302. [PMID: 23108389 DOI: 10.1007/s10555-012-9414-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
489 Gentner B, Naldini L. Exploiting microRNA regulation for genetic engineering. Tissue Antigens. 2012;80:393-403. [PMID: 23020307 DOI: 10.1111/tan.12002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
490 Das A, Sen CK. NutrimiRomics. In: Bagchi D, Swaroop A, Bagchi M, editors. Genomics, Proteomics and Metabolomics in Nutraceuticals and Functional Foods. Chichester: John Wiley & Sons, Ltd; 2015. pp. 53-60. [DOI: 10.1002/9781118930458.ch5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
491 Oien KA, Evans TR. Raising the profile of cancer of unknown primary. J Clin Oncol 2008;26:4373-5. [PMID: 18802148 DOI: 10.1200/JCO.2008.17.6156] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
492 Gal H, Pandi G, Kanner AA, Ram Z, Lithwick-Yanai G, Amariglio N, Rechavi G, Givol D. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem Biophys Res Commun 2008;376:86-90. [PMID: 18765229 DOI: 10.1016/j.bbrc.2008.08.107] [Cited by in Crossref: 166] [Cited by in F6Publishing: 154] [Article Influence: 11.9] [Reference Citation Analysis]
493 Selth LA, Tilley WD, Butler LM. Circulating microRNAs: macro-utility as markers of prostate cancer? Endocr Relat Cancer 2012;19:R99-R113. [PMID: 22492480 DOI: 10.1530/ERC-12-0010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
494 Zhou X, Tian L, Fan J, Lai Y, Li S, Che G, Huang J. Method for discriminating synchronous multiple lung cancers of the same histological type: miRNA expression analysis. Medicine (Baltimore) 2016;95:e4478. [PMID: 27495091 DOI: 10.1097/MD.0000000000004478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
495 Kao HW, Pan CY, Lai CH, Wu CW, Fang WL, Huang KH, Lin WC. Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer. Oncotarget 2017;8:56389-97. [PMID: 28915598 DOI: 10.18632/oncotarget.16916] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
496 Margaritis K, Margioula-Siarkou G, Margioula-Siarkou C, Petousis S, Kotanidou EP, Christoforidis A, Pavlou E, Galli-Tsinopoulou A. Circulating serum and plasma levels of micro-RNA in type-1 diabetes in children and adolescents: A systematic review and meta-analysis. Eur J Clin Invest 2021;51:e13510. [PMID: 33565089 DOI: 10.1111/eci.13510] [Reference Citation Analysis]
497 Majid S, Dar AA, Saini S, Arora S, Shahryari V, Zaman MS, Chang I, Yamamura S, Tanaka Y, Deng G, Dahiya R. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res 2012;72:6435-46. [PMID: 23074286 DOI: 10.1158/0008-5472.CAN-12-2181] [Cited by in Crossref: 107] [Cited by in F6Publishing: 65] [Article Influence: 10.7] [Reference Citation Analysis]
498 Allon I, Pessing A, Kaplan I, Allon DM, Hirshberg A. Metastatic tumors to the gingiva and the presence of teeth as a contributing factor: a literature analysis. J Periodontol 2014;85:132-9. [PMID: 23646853 DOI: 10.1902/jop.2013.130118] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
499 Gravgaard KH, Lyng MB, Laenkholm AV, Søkilde R, Nielsen BS, Litman T, Ditzel HJ. The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer. Breast Cancer Res Treat. 2012;134:207-217. [PMID: 22294488 DOI: 10.1007/s10549-012-1969-9] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
500 Kedmi M, Sas-Chen A, Yarden Y. MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression. J Clin Med 2015;4:1578-99. [PMID: 26287249 DOI: 10.3390/jcm4081578] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
501 Fatima A, Morris DG. MicroRNAs in domestic livestock. Physiological Genomics 2013;45:685-96. [DOI: 10.1152/physiolgenomics.00009.2013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
502 Ling H, Girnita L, Buda O, Calin GA. Non-coding RNAs: the cancer genome dark matter that matters! Clin Chem Lab Med 2017;55:705-14. [PMID: 27988500 DOI: 10.1515/cclm-2016-0740] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
503 Yu CY, Mitrofanova A. Mechanism-Centric Approaches for Biomarker Detection and Precision Therapeutics in Cancer. Front Genet 2021;12:687813. [PMID: 34408770 DOI: 10.3389/fgene.2021.687813] [Reference Citation Analysis]
504 Lim WK, Micklem G. MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways. Mol Biosyst 2011;7:2571-6. [PMID: 21766137 DOI: 10.1039/c1mb05181d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
505 Khare D, Goldschmidt N, Bardugo A, Gur-Wahnon D, Ben-Dov IZ, Avni B. Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance. PLoS One 2017;12:e0187722. [PMID: 29131834 DOI: 10.1371/journal.pone.0187722] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
506 Tumilson CA, Lea RW, Alder JE, Shaw L. Circulating microRNA biomarkers for glioma and predicting response to therapy. Mol Neurobiol 2014;50:545-58. [PMID: 24696266 DOI: 10.1007/s12035-014-8679-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
507 Kotaja N. MicroRNAs and spermatogenesis. Fertil Steril. 2014;101:1552-1562. [PMID: 24882619 DOI: 10.1016/j.fertnstert.2014.04.025] [Cited by in Crossref: 138] [Cited by in F6Publishing: 137] [Article Influence: 17.3] [Reference Citation Analysis]
508 Laprovitera N, Riefolo M, Porcellini E, Durante G, Garajova I, Vasuri F, Aigelsreiter A, Dandachi N, Benvenuto G, Agostinis F, Sabbioni S, Berindan Neagoe I, Romualdi C, Ardizzoni A, Trerè D, Pichler M, D'Errico A, Ferracin M. MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary. Mol Oncol 2021. [PMID: 34075699 DOI: 10.1002/1878-0261.13026] [Reference Citation Analysis]
509 Fu X, Xue C, Huang Y, Xie Y, Li Y. The activity and expression of microRNAs in prostate cancers. Mol Biosyst 2010;6:2561-72. [PMID: 20957285 DOI: 10.1039/c0mb00100g] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
510 Sun D, Han S, Liu C, Zhou R, Sun W, Zhang Z, Qu J. Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma. Med Sci Monit 2016;22:1210-7. [PMID: 27062921 DOI: 10.12659/msm.895788] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
511 Zhang Y, Zheng X, Xia L, You J, Ren R. A nucleic acid logic gate system that distinguishes different sets of inputs from one miRNA collection with shared members. RSC Adv 2017;7:42345-9. [DOI: 10.1039/c7ra05807a] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
512 Guancial EA, Chowdhury D, Rosenberg JE. Personalized therapy for urothelial cancer: review of the clinical evidence. Clin Investig (Lond) 2011;1:546-55. [PMID: 22754656 DOI: 10.4155/cli.11.26] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
513 Wani JA, Majid S, Khan A, Arafah A, Ahmad A, Jan BL, Shah NN, Kazi M, Rehman MU. Clinico-Pathological Importance of miR-146a in Lung Cancer. Diagnostics (Basel) 2021;11:274. [PMID: 33578944 DOI: 10.3390/diagnostics11020274] [Reference Citation Analysis]
514 Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 2009;4:e6229. [PMID: 19597549 DOI: 10.1371/journal.pone.0006229] [Cited by in Crossref: 285] [Cited by in F6Publishing: 282] [Article Influence: 21.9] [Reference Citation Analysis]
515 Armand-labit V, Pradines A. Circulating cell-free microRNAs as clinical cancer biomarkers. Biomolecular Concepts 2017;8:61-81. [DOI: 10.1515/bmc-2017-0002] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 18.0] [Reference Citation Analysis]
516 Fletcher AM, Heaford AC, Trask DK. Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl Oncol 2008;1:202-8. [PMID: 19043531 DOI: 10.1593/tlo.08163] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
517 Piehl F, Jagodic M. MicroRNAs as promising novel biomarkers and potential drug targets for inflammatory neurological diseases. Journal of the Neurological Sciences 2015;356:3-4. [DOI: 10.1016/j.jns.2015.06.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
518 Ravegnini G, Serrano C, Ricci R, Zhang Q, Terrenato I, Graziosi A, Valori G, Landolfi S, Hrelia P, Angelini S. miRNA landscape in primary tumors and matched metastases in gastrointestinal stromal tumors. Epigenomics 2021;13:369-77. [PMID: 33432846 DOI: 10.2217/epi-2020-0303] [Reference Citation Analysis]
519 Toffanin S, Hoshida Y, Lachenmayer A, Villanueva A, Cabellos L, Minguez B, Savic R, Ward SC, Thung S, Chiang DY. MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology. 2011;140:1618-1628.e16. [PMID: 21324318 DOI: 10.1053/j.gastro.2011.02.009] [Cited by in Crossref: 153] [Cited by in F6Publishing: 151] [Article Influence: 13.9] [Reference Citation Analysis]
520 Paranjape T, Slack FJ, Weidhaas JB. MicroRNAs: tools for cancer diagnostics. Gut 2009;58:1546-54. [PMID: 19834118 DOI: 10.1136/gut.2009.179531] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 6.7] [Reference Citation Analysis]
521 Trang P, Weidhaas JB, Slack FJ. MicroRNAs as potential cancer therapeutics. Oncogene. 2008;27 Suppl 2:S52-S57. [PMID: 19956180 DOI: 10.1038/onc.2009.353] [Cited by in Crossref: 148] [Cited by in F6Publishing: 156] [Article Influence: 12.3] [Reference Citation Analysis]
522 Chen WC, Lin MS, Huang JX, Ye YL, Gao HJ, Song ZY, Shen XY. Clinical significance of aberrant microRNAs expression in human colorectal cancer. Shijie Huaren Xiaohua Zazhi 2010; 18(30): 3187-3194 [DOI: 10.11569/wcjd.v18.i30.3187] [Reference Citation Analysis]
523 Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin. 2010;60:376-392. [PMID: 20959400 DOI: 10.3322/caac.20085] [Cited by in Crossref: 288] [Cited by in F6Publishing: 273] [Article Influence: 24.0] [Reference Citation Analysis]
524 Liu MZ, McLeod HL, He FZ, Chen XP, Zhou HH, Shu Y, Zhang W. Epigenetic perspectives on cancer chemotherapy response. Pharmacogenomics 2014;15:699-715. [PMID: 24798726 DOI: 10.2217/pgs.14.41] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
525 Margaritis K, Margioula-Siarkou G, Giza S, Kotanidou EP, Tsinopoulou VR, Christoforidis A, Galli-Tsinopoulou A. Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature. Int J Mol Sci 2021;22:12165. [PMID: 34830046 DOI: 10.3390/ijms222212165] [Reference Citation Analysis]
526 Andersen GB, Tost J. Circulating miRNAs as Biomarker in Cancer. Recent Results Cancer Res 2020;215:277-98. [PMID: 31605235 DOI: 10.1007/978-3-030-26439-0_15] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
527 Shen J, Jiang F. Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer. Expert Opin Med Diagn 2012;6:197-207. [PMID: 22615714 DOI: 10.1517/17530059.2012.672970] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
528 Garzon R, Marcucci G. Potential of microRNAs for cancer diagnostics, prognostication and therapy. Current Opinion in Oncology 2012;24:655-9. [DOI: 10.1097/cco.0b013e328358522c] [Cited by in Crossref: 49] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]
529 Hromadnikova I, Kotlabova K, Hympanova L, Krofta L. Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction. PLoS One 2015;10:e0138383. [PMID: 26394310 DOI: 10.1371/journal.pone.0138383] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 10.0] [Reference Citation Analysis]
530 Lee JC, Zhao JT, Clifton-Bligh RJ, Gill A, Gundara JS, Ip JC, Glover A, Sywak MS, Delbridge LW, Robinson BG, Sidhu SB. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer 2013;119:4358-65. [PMID: 24301304 DOI: 10.1002/cncr.28254] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 11.0] [Reference Citation Analysis]
531 Zachariah MA, Oliveira-Costa JP, Carter BS, Stott SL, Nahed BV. Blood-based biomarkers for the diagnosis and monitoring of gliomas. Neuro Oncol 2018;20:1155-61. [PMID: 29746665 DOI: 10.1093/neuonc/noy074] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
532 Harati R, Mohammad MG, Tlili A, El-Awady RA, Hamoudi R. Loss of miR-101-3p Promotes Transmigration of Metastatic Breast Cancer Cells through the Brain Endothelium by Inducing COX-2/MMP1 Signaling. Pharmaceuticals (Basel) 2020;13:E144. [PMID: 32645833 DOI: 10.3390/ph13070144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
533 Ruiz-Bañobre J, Goel A. Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy. Adv Cancer Res 2021;151:231-304. [PMID: 34148615 DOI: 10.1016/bs.acr.2021.02.008] [Reference Citation Analysis]
534 Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6:590-610. [PMID: 23102669 DOI: 10.1016/j.molonc.2012.09.006.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
535 Zhang S, Zhang C, Du J, Zhang R, Yang S, Li B, Wang P, Deng W. Prediction of Lymph-Node Metastasis in Cancers Using Differentially Expressed mRNA and Non-coding RNA Signatures. Front Cell Dev Biol 2021;9:605977. [PMID: 33644044 DOI: 10.3389/fcell.2021.605977] [Reference Citation Analysis]
536 Wan Z, Umer M, Lobino M, Thiel D, Nguyen N, Trinchi A, Shiddiky MJ, Gao Y, Li Q. Laser induced self-N-doped porous graphene as an electrochemical biosensor for femtomolar miRNA detection. Carbon 2020;163:385-94. [DOI: 10.1016/j.carbon.2020.03.043] [Cited by in Crossref: 33] [Cited by in F6Publishing: 6] [Article Influence: 16.5] [Reference Citation Analysis]
537 Brase JC, Wuttig D, Kuner R, Sültmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer. 2010;9:306. [PMID: 21110877 DOI: 10.1186/1476-4598-9-306] [Cited by in Crossref: 281] [Cited by in F6Publishing: 278] [Article Influence: 23.4] [Reference Citation Analysis]
538 Luo Y, Wang C, Chen X, Zhong T, Cai X, Chen S, Shi Y, Hu J, Guan X, Xia Z, Wang J, Zen K, Zhang CY, Zhang C. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem. 2013;59:658-666. [PMID: 23344497 DOI: 10.1373/clinchem.2012.195297] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 8.4] [Reference Citation Analysis]
539 Gustafson D, Tyryshkin K, Renwick N. microRNA-guided diagnostics in clinical samples. Best Practice & Research Clinical Endocrinology & Metabolism 2016;30:563-75. [DOI: 10.1016/j.beem.2016.07.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
540 Guo L, Li H, Zhao R, Tang Y, Li B. Sensitive, general and portable detection of RNAs combining duplex-specific nuclease transduction with an off-shelf signalling platform. Chem Commun (Camb) 2021;57:5714-7. [PMID: 33982719 DOI: 10.1039/d1cc01715b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
541 Agulló-ortuño MT, López-ríos F, Paz-ares L. Lung Cancer Genomic Signatures. Journal of Thoracic Oncology 2010;5:1673-91. [DOI: 10.1097/jto.0b013e3181f1900e] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
542 Kolokythas A, Miloro M, Zhou X. Review of MicroRNA Deregulation in Oral Cancer. Part I. J Oral Maxillofac Res 2011;2:e1. [PMID: 24421988 DOI: 10.5037/jomr.2011.2201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
543 Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 2010;30:35-51. [PMID: 20175032 DOI: 10.1055/s-0030-1247131] [Cited by in Crossref: 212] [Cited by in F6Publishing: 211] [Article Influence: 17.7] [Reference Citation Analysis]
544 Wan Z, Nguyen N, Gao Y, Li Q. Laser induced graphene for biosensors. Sustainable Materials and Technologies 2020;25:e00205. [DOI: 10.1016/j.susmat.2020.e00205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
545 Xing F, Sharma S, Liu Y, Mo YY, Wu K, Zhang YY, Pochampally R, Martinez LA, Lo HW, Watabe K. miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α. Oncogene 2015;34:4890-900. [PMID: 25659578 DOI: 10.1038/onc.2014.412] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
546 Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M, Santamarina I, Blanco M, Fernández-Tajes J, Quindós M, Carral A, Figueroa A, Antón-Aparicio LM, Calvo L. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 2012;10:186. [PMID: 22954417 DOI: 10.1186/1479-5876-10-186] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 9.5] [Reference Citation Analysis]
547 Xu J, Zou J, Wu L, Lu W. Transcriptome analysis uncovers the diagnostic value of miR-192-5p/HNF1A-AS1/VIL1 panel in cervical adenocarcinoma. Sci Rep 2020;10:16584. [PMID: 33024199 DOI: 10.1038/s41598-020-73523-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
548 Morris GJ, Greco FA, Hainsworth JD, Engstrom PF, Scialla S, Jordan WE, Thomas LC. Cancer of Unknown Primary Site. Seminars in Oncology 2010;37:71-9. [DOI: 10.1053/j.seminoncol.2010.03.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
549 Shoji H, Isomoto H, Yoshida A, Ikeda H, Minami H, Kanda T, Urabe S, Matsushima K, Takeshima F, Nakao K, Inoue H. MicroRNA-130a is highly expressed in the esophageal mucosa of achalasia patients. Exp Ther Med 2017;14:898-904. [PMID: 28810541 DOI: 10.3892/etm.2017.4598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
550 Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem. 2011;286:25992-26002. [PMID: 21596753 DOI: 10.1074/jbc.m111.229401] [Cited by in Crossref: 191] [Cited by in F6Publishing: 125] [Article Influence: 17.4] [Reference Citation Analysis]
551 Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang Z, Chen F, Zheng G. Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One. 2012;7:e40037. [PMID: 22802949 DOI: 10.1371/journal.pone.0040037] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 6.4] [Reference Citation Analysis]
552 Qin Y, Yao J, Wu DC, Nottingham RM, Mohr S, Hunicke-Smith S, Lambowitz AM. High-throughput sequencing of human plasma RNA by using thermostable group II intron reverse transcriptases. RNA 2016;22:111-28. [PMID: 26554030 DOI: 10.1261/rna.054809.115] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 9.1] [Reference Citation Analysis]
553 Costa FF, Bischof JM, Vanin EF, Lulla RR, Wang M, Sredni ST, Rajaram V, Bonaldo Mde F, Wang D, Goldman S, Tomita T, Soares MB. Identification of microRNAs as potential prognostic markers in ependymoma. PLoS One 2011;6:e25114. [PMID: 22053178 DOI: 10.1371/journal.pone.0025114] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 7.3] [Reference Citation Analysis]
554 Greco FA, Lennington WJ, Spigel DR, Hainsworth JD. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology. J Natl Cancer Inst 2013;105:782-90. [PMID: 23641043 DOI: 10.1093/jnci/djt099] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 7.8] [Reference Citation Analysis]
555 Cava C, Bertoli G, Castiglioni I. Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential. BMC Syst Biol 2015;9:62. [PMID: 26391647 DOI: 10.1186/s12918-015-0211-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
556 Zheng Q, Hou W. Regulation of angiogenesis by microRNAs in cancer. Mol Med Rep 2021;24:583. [PMID: 34132365 DOI: 10.3892/mmr.2021.12222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
557 Reddy AM, Zheng Y, Jagadeeswaran G, Macmil SL, Graham WB, Roe BA, Desilva U, Zhang W, Sunkar R. Cloning, characterization and expression analysis of porcine microRNAs. BMC Genomics. 2009;10:65. [PMID: 19196471 DOI: 10.1186/1471-2164-10-65] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
558 Kwok GT, Zhao JT, Weiss J, Mugridge N, Brahmbhatt H, MacDiarmid JA, Robinson BG, Sidhu SB. Translational applications of microRNAs in cancer, and therapeutic implications. Noncoding RNA Res 2017;2:143-50. [PMID: 30159433 DOI: 10.1016/j.ncrna.2017.12.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
559 Chun HE, Lim EL, Heravi-Moussavi A, Saberi S, Mungall KL, Bilenky M, Carles A, Tse K, Shlafman I, Zhu K, Qian JQ, Palmquist DL, He A, Long W, Goya R, Ng M, LeBlanc VG, Pleasance E, Thiessen N, Wong T, Chuah E, Zhao YJ, Schein JE, Gerhard DS, Taylor MD, Mungall AJ, Moore RA, Ma Y, Jones SJM, Perlman EJ, Hirst M, Marra MA. Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways. Cancer Cell 2016;29:394-406. [PMID: 26977886 DOI: 10.1016/j.ccell.2016.02.009] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 13.2] [Reference Citation Analysis]
560 Giannoudis A, Clarke K, Zakaria R, Varešlija D, Farahani M, Rainbow L, Platt-Higgins A, Ruthven S, Brougham KA, Rudland PS, Jenkinson MD, Young LS, Falciani F, Palmieri C. A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival. Sci Rep 2019;9:18518. [PMID: 31811234 DOI: 10.1038/s41598-019-55084-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
561 Yokoi A, Yoshioka Y, Ochiya T. Towards the realization of clinical extracellular vesicle diagnostics: challenges and opportunities. Expert Review of Molecular Diagnostics 2015;15:1555-66. [DOI: 10.1586/14737159.2015.1104249] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
562 Pichler M, Calin GA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer 2015;113:569-73. [PMID: 26158421 DOI: 10.1038/bjc.2015.253] [Cited by in Crossref: 140] [Cited by in F6Publishing: 124] [Article Influence: 20.0] [Reference Citation Analysis]
563 Vaksman O, Stavnes HT, Kaern J, Trope CG, Davidson B, Reich R. miRNA profiling along tumour progression in ovarian carcinoma. J Cell Mol Med 2011;15:1593-602. [PMID: 20716115 DOI: 10.1111/j.1582-4934.2010.01148.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 7.9] [Reference Citation Analysis]
564 Tan DS, Montoya J, Ng Q, Chan K, Lynette O, Sakktee Krisna S, Takano A, Lim W, Tan E, Lim K. Molecular Profiling for Druggable Genetic Abnormalities in Carcinoma of Unknown Primary. JCO 2013;31:e237-9. [DOI: 10.1200/jco.2012.44.3937] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
565 Detassis S, Grasso M, Del Vescovo V, Denti MA. microRNAs Make the Call in Cancer Personalized Medicine. Front Cell Dev Biol 2017;5:86. [PMID: 29018797 DOI: 10.3389/fcell.2017.00086] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
566 Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP. The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) 2012;5:992-1006. [PMID: 22689914 DOI: 10.1158/1940-6207.CAPR-11-0441] [Cited by in Crossref: 140] [Cited by in F6Publishing: 87] [Article Influence: 14.0] [Reference Citation Analysis]
567 Tothill RW, Shi F, Paiman L, Bedo J, Kowalczyk A, Mileshkin L, Buela E, Klupacs R, Bowtell D, Byron K. Development and validation of a gene expression tumour classifier for cancer of unknown primary. Pathology 2015;47:7-12. [PMID: 25485653 DOI: 10.1097/PAT.0000000000000194] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
568 Delaloy C, Liu L, Lee JA, Su H, Shen F, Yang GY, Young WL, Ivey KN, Gao FB. MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell. 2010;6:323-335. [PMID: 20362537 DOI: 10.1016/j.stem.2010.02.015] [Cited by in Crossref: 231] [Cited by in F6Publishing: 229] [Article Influence: 19.3] [Reference Citation Analysis]
569 Berger F, Reiser MF. Micro-RNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences? Theranostics. 2013;3:943-952. [PMID: 24396505 DOI: 10.7150/thno.7445] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
570 Shen X, Fang J, Lv X, Pei Z, Wang Y, Jiang S, Ding K. Heparin impairs angiogenesis through inhibition of microRNA-10b. J Biol Chem 2011;286:26616-27. [PMID: 21642433 DOI: 10.1074/jbc.M111.224212] [Cited by in Crossref: 50] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
571 Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis 2012;33:1126-33. [PMID: 22491715 DOI: 10.1093/carcin/bgs140] [Cited by in Crossref: 375] [Cited by in F6Publishing: 371] [Article Influence: 37.5] [Reference Citation Analysis]
572 Chan E, Prado DE, Weidhaas JB. Cancer microRNAs: from subtype profiling to predictors of response to therapy. Trends Mol Med 2011;17:235-43. [PMID: 21354374 DOI: 10.1016/j.molmed.2011.01.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
573 Muñoz-largacha JA, Gower AC, Sridhar P, Deshpande A, O'hara CJ, Yamada E, Godfrey TE, Fernando HC, Litle VR. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma. The Journal of Thoracic and Cardiovascular Surgery 2017;154:714-27. [DOI: 10.1016/j.jtcvs.2017.02.071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
574 Yu Y, He J. Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis. Front Med 2013;7:157-71. [PMID: 23681892 DOI: 10.1007/s11684-013-0272-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
575 Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4:143-159. [PMID: 22351564 DOI: 10.1007/978-1-62703-547-7_14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
576 Lee JC, Gundara JS, Glover A, Serpell J, Sidhu SB. MicroRNA expression profiles in the management of papillary thyroid cancer. Oncologist 2014;19:1141-7. [PMID: 25323484 DOI: 10.1634/theoncologist.2014-0135] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
577 Hui P, Gysler SM, Uduman M, Togun TA, Prado DE, Brambs CE, Nallur S, Schwartz PE, Rutherford TJ, Santin AD, Weidhaas JB, Ratner ES. MicroRNA signatures discriminate between uterine and ovarian serous carcinomas. Human Pathology 2018;76:133-40. [DOI: 10.1016/j.humpath.2018.02.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
578 Meiri E, Levy A, Benjamin H, Ben-David M, Cohen L, Dov A, Dromi N, Elyakim E, Yerushalmi N, Zion O, Lithwick-Yanai G, Sitbon E. Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res 2010;38:6234-46. [PMID: 20483914 DOI: 10.1093/nar/gkq376] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 7.0] [Reference Citation Analysis]
579 Pass HI, Goparaju C, Ivanov S, Donington J, Carbone M, Hoshen M, Cohen D, Chajut A, Rosenwald S, Dan H, Benjamin S, Aharonov R. hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res 2010;70:1916-24. [PMID: 20160038 DOI: 10.1158/0008-5472.CAN-09-3993] [Cited by in Crossref: 108] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
580 Hydbring P, Badalian-Very G. Clinical applications of microRNAs. F1000Res 2013;2:136. [PMID: 24627783 DOI: 10.12688/f1000research.2-136.v3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
581 Sabbah M, Emami S, Redeuilh G, Julien S, Prévost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat. 2008;11:123-151. [PMID: 18718806 DOI: 10.1016/j.drup.2008.07.001] [Cited by in Crossref: 215] [Cited by in F6Publishing: 203] [Article Influence: 15.4] [Reference Citation Analysis]
582 Alečković M, Kang Y. Regulation of cancer metastasis by cell-free miRNAs. Biochim Biophys Acta 2015;1855:24-42. [PMID: 25450578 DOI: 10.1016/j.bbcan.2014.10.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 53] [Article Influence: 2.6] [Reference Citation Analysis]
583 Baley J, Li J. MicroRNAs and ovarian function. J Ovarian Res 2012;5:8. [PMID: 22321819 DOI: 10.1186/1757-2215-5-8] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 6.7] [Reference Citation Analysis]
584 Blandino G, Fazi F, Donzelli S, Kedmi M, Sas-Chen A, Muti P, Strano S, Yarden Y. Tumor suppressor microRNAs: a novel non-coding alliance against cancer. FEBS Lett 2014;588:2639-52. [PMID: 24681102 DOI: 10.1016/j.febslet.2014.03.033] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
585 Ullah MF, Aatif M. The footprints of cancer development: Cancer biomarkers. Cancer Treat Rev 2009;35:193-200. [PMID: 19062197 DOI: 10.1016/j.ctrv.2008.10.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 5.6] [Reference Citation Analysis]
586 LaConti JJ, Shivapurkar N, Preet A, Deslattes Mays A, Peran I, Kim SE, Marshall JL, Riegel AT, Wellstein A. Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS One. 2011;6:e20687. [PMID: 21738581 DOI: 10.1371/journal.pone.0020687] [Cited by in Crossref: 56] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
587 Cui G, Liu D, Li W, Li Y, Liang Y, Shi W, Zhao S. Original Research: miR-194 inhibits proliferation and invasion and promotes apoptosis by targeting KDM5B in esophageal squamous cell carcinoma cells. Exp Biol Med (Maywood) 2017;242:45-52. [PMID: 27480251 DOI: 10.1177/1535370216662712] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
588 Shahrouki P, Larsson E. The non-coding oncogene: a case of missing DNA evidence? Front Genet 2012;3:170. [PMID: 22988449 DOI: 10.3389/fgene.2012.00170] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
589 Elson-Schwab I, Lorentzen A, Marshall CJ. MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One 2010;5:e13176. [PMID: 20957176 DOI: 10.1371/journal.pone.0013176] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 7.5] [Reference Citation Analysis]
590 Sabry OM, Sabry MO, El-Sonbaty SM, Meselhy KM. Eucalyptus kino: a treasure trove of polyphenols eradicating tumors in-vivo by elevating caspase-3 level, inhibiting TGF-β and NF-κb gene expression. Nat Prod Res 2021;:1-6. [PMID: 33886378 DOI: 10.1080/14786419.2021.1916018] [Reference Citation Analysis]
591 Sørensen KD, Ørntoft TF. Discovery of prostate cancer biomarkers by microarray gene expression profiling. Expert Rev Mol Diagn 2010;10:49-64. [PMID: 20014922 DOI: 10.1586/erm.09.74] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
592 Nadal E, Truini A, Nakata A, Lin J, Reddy RM, Chang AC, Ramnath N, Gotoh N, Beer DG, Chen G. A Novel Serum 4-microRNA Signature for Lung Cancer Detection. Sci Rep 2015;5:12464. [PMID: 26202143 DOI: 10.1038/srep12464] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 9.6] [Reference Citation Analysis]
593 Feinmesser M, Benbassat C, Meiri E, Benjamin H, Lebanony D, Lebenthal Y, de Vries L, Drozd T, Spector Y. Specific MicroRNAs Differentiate Adrenocortical Adenomas from Carcinomas and Correlate With Weiss Histopathologic System. Appl Immunohistochem Mol Morphol 2015;23:522-31. [PMID: 25265426 DOI: 10.1097/PAI.0000000000000117] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
594 Barshack I, Lithwick-Yanai G, Afek A, Rosenblatt K, Tabibian-Keissar H, Zepeniuk M, Cohen L, Dan H, Zion O, Strenov Y. MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol Res Pract. 2010;206:578-584. [PMID: 20418022 DOI: 10.1016/j.prp.2010.03.005] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
595 Kabzinski J, Maczynska M, Majsterek I. MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer. Biomolecules 2021;11:844. [PMID: 34198889 DOI: 10.3390/biom11060844] [Reference Citation Analysis]
596 Markou A, Liang Y, Lianidou E. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clin Chem Lab Med 2011;49:1591-603. [PMID: 21767219 DOI: 10.1515/CCLM.2011.661] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
597 Begum S, Hayashi M, Ogawa T, Jabboure FJ, Brait M, Izumchenko E, Tabak S, Ahrendt SA, Westra WH, Koch W. An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation. Sci Rep. 2015;5:13236. [PMID: 26314549 DOI: 10.1038/srep13236] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
598 Li X, Lin Y, Gu C, Yang J. FCMDAP: using miRNA family and cluster information to improve the prediction accuracy of disease related miRNAs. BMC Syst Biol 2019;13:26. [PMID: 30953512 DOI: 10.1186/s12918-019-0696-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
599 Aisner DL, Theodorescu D. Genetic testing for metastasis: potential for improved cancer treatment. Future Oncol 2011;7:697-701. [PMID: 21675831 DOI: 10.2217/fon.11.48] [Reference Citation Analysis]
600 Zaimy MA, Saffarzadeh N, Mohammadi A, Pourghadamyari H, Izadi P, Sarli A, Moghaddam LK, Paschepari SR, Azizi H, Torkamandi S, Tavakkoly-Bazzaz J. New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Ther 2017;24:233-43. [PMID: 28574057 DOI: 10.1038/cgt.2017.16] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 7.2] [Reference Citation Analysis]
601 Gao W, Xu J, Shu YQ. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer. Expert Rev Respir Med 2011;5:699-709. [PMID: 21955239 DOI: 10.1586/ers.11.55] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
602 Cheng HH, Mitchell PS, Kroh EM, Dowell AE, Chéry L, Siddiqui J, Nelson PS, Vessella RL, Knudsen BS, Chinnaiyan AM. Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia. PLoS One. 2013;8:e69239. [PMID: 23935962 DOI: 10.1371/journal.pone.0069239] [Cited by in Crossref: 112] [Cited by in F6Publishing: 116] [Article Influence: 12.4] [Reference Citation Analysis]
603 Koo H, Park I, Lee Y, Kim HJ, Jung JH, Lee JH, Kim Y, Kim JH, Park JW. Visualization and Quantification of MicroRNA in a Single Cell Using Atomic Force Microscopy. J Am Chem Soc 2016;138:11664-71. [PMID: 27529574 DOI: 10.1021/jacs.6b05048] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
604 Telonis AG, Magee R, Loher P, Chervoneva I, Londin E, Rigoutsos I. Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types. Nucleic Acids Res 2017;45:2973-85. [PMID: 28206648 DOI: 10.1093/nar/gkx082] [Cited by in Crossref: 101] [Cited by in F6Publishing: 87] [Article Influence: 20.2] [Reference Citation Analysis]
605 Jeffrey SS. Cancer biomarker profiling with microRNAs. Nat Biotechnol 2008;26:400-1. [PMID: 18392022 DOI: 10.1038/nbt0408-400] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 5.7] [Reference Citation Analysis]
606 Kumar B, Lupold SE. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery. Asian J Androl 2016;18:559-67. [PMID: 27056344 DOI: 10.4103/1008-682X.177839] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 6.2] [Reference Citation Analysis]
607 Barshack I, Meiri E, Rosenwald S, Lebanony D, Bronfeld M, Aviel-ronen S, Rosenblatt K, Polak-charcon S, Leizerman I, Ezagouri M, Zepeniuk M, Shabes N, Cohen L, Tabak S, Cohen D, Bentwich Z, Rosenfeld N. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression. The International Journal of Biochemistry & Cell Biology 2010;42:1355-62. [DOI: 10.1016/j.biocel.2009.02.021] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
608 Wen XQ, Qian XL, Sun HK, Zheng LL, Zhu WQ, Li TY, Hu JP. MicroRNAs: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications. Onco Targets Ther 2020;13:10851-66. [PMID: 33149603 DOI: 10.2147/OTT.S265580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
609 Rigakos G, Vakos A, Papadopoulos S, Vernadou A, Tsimpidakis A, Papachristou D, Razis E. Cancer of unknown primary ultimately diagnosed as male breast cancer: A rare case report. Mol Clin Oncol 2016;5:263-6. [PMID: 27446561 DOI: 10.3892/mco.2016.912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
610 Sun W, Lan X, Wang Z, Dong W, He L, Zhang T, Zhang P, Zhang H. MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer. Oncol Lett 2018;15:1007-13. [PMID: 29399161 DOI: 10.3892/ol.2017.7440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
611 Schnabel CA, Erlander MG. Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumors. Expert Opin Med Diagn 2012;6:407-19. [PMID: 23480806 DOI: 10.1517/17530059.2012.704363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
612 Vineetha S, Chandra Shekara Bhat C, Idicula SM. MicroRNA–mRNA interaction network using TSK-type recurrent neural fuzzy network. Gene 2013;515:385-90. [DOI: 10.1016/j.gene.2012.12.063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
613 Xuan Y, Yang H, Zhao L, Lau WB, Lau B, Ren N, Hu Y, Yi T, Zhao X, Zhou S. MicroRNAs in colorectal cancer: Small molecules with big functions. Cancer Lett. 2014; Dec 15. [Epub ahead of print]. [PMID: 25524553 DOI: 10.1016/j.canlet.2014.11.051] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
614 Colden M, Dar AA, Saini S, Dahiya PV, Shahryari V, Yamamura S, Tanaka Y, Stein G, Dahiya R, Majid S. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Cell Death Dis 2017;8:e2572. [PMID: 28125091 DOI: 10.1038/cddis.2017.15] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 13.6] [Reference Citation Analysis]
615 Kim TM, Huang W, Park R, Park PJ, Johnson MD. A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res 2011;71:3387-99. [PMID: 21385897 DOI: 10.1158/0008-5472.CAN-10-4117] [Cited by in Crossref: 131] [Cited by in F6Publishing: 94] [Article Influence: 11.9] [Reference Citation Analysis]
616 De Guire V, Robitaille R, Tétreault N, Guérin R, Ménard C, Bambace N, Sapieha P. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin Biochem. 2013;46:846-860. [PMID: 23562576 DOI: 10.1016/j.clinbiochem.2013.03.015] [Cited by in Crossref: 145] [Cited by in F6Publishing: 141] [Article Influence: 16.1] [Reference Citation Analysis]
617 Zheng C, Xu R. Predicting cancer origins with a DNA methylation-based deep neural network model. PLoS One 2020;15:e0226461. [PMID: 32384093 DOI: 10.1371/journal.pone.0226461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
618 Gattolliat CH, Uguen A, Pesson M, Trillet K, Simon B, Doucet L, Robaszkiewicz M, Corcos L. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas. Eur J Cancer. 2015;51:409-420. [PMID: 25586944 DOI: 10.1016/j.ejca.2014.12.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
619 Garg S, Shah S, Bui H, Song T, Mokhtar R, Reif J. Renewable Time‐Responsive DNA Circuits. Small 2018;14:1801470. [DOI: 10.1002/smll.201801470] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
620 Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS, Tewari M. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One 2009;4:e5311. [PMID: 19390579 DOI: 10.1371/journal.pone.0005311] [Cited by in Crossref: 172] [Cited by in F6Publishing: 162] [Article Influence: 13.2] [Reference Citation Analysis]
621 Mitchell PS, Tewari M. Circulating MicroRNAs in Cancer. In: Kikuchi Y, Rykova EY, editors. Extracellular Nucleic Acids. Berlin: Springer Berlin Heidelberg; 2010. pp. 129-45. [DOI: 10.1007/978-3-642-12617-8_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
622 Leichter AL, Purcell RV, Sullivan MJ, Eccles MR, Chatterjee A. Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples. Gigascience 2015;4:54. [PMID: 26613016 DOI: 10.1186/s13742-015-0099-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
623 Huang Q, Ouyang X. Predictive biochemical-markers for the development of brain metastases from lung cancer: clinical evidence and future directions. Cancer Epidemiol 2013;37:703-7. [PMID: 23816974 DOI: 10.1016/j.canep.2013.06.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
624 Beier M, Boisguérin V. Microfluidic Primer Extension Assay. In: Fan J, editor. Next-Generation MicroRNA Expression Profiling Technology. Totowa: Humana Press; 2012. pp. 143-52. [DOI: 10.1007/978-1-61779-427-8_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
625 Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13:358-369. [PMID: 22510765 DOI: 10.1038/nrg3198] [Cited by in Crossref: 1026] [Cited by in F6Publishing: 940] [Article Influence: 102.6] [Reference Citation Analysis]
626 Wei IH, Shi Y, Jiang H, Kumar-Sinha C, Chinnaiyan AM. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin. Neoplasia 2014;16:918-27. [PMID: 25425966 DOI: 10.1016/j.neo.2014.09.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
627 Gyongyosi A, Docs O, Czimmerer Z, Orosz L, Horvath A, Török O, Mehes G, Nagy L, Balint BL. Measuring expression levels of small regulatory RNA molecules from body fluids and formalin-fixed, paraffin-embedded samples. Methods Mol Biol 2014;1182:105-19. [PMID: 25055905 DOI: 10.1007/978-1-4939-1062-5_10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
628 Hydbring P, Badalian-Very G. Clinical applications of microRNAs. F1000Res 2013;2:136. [PMID: 24627783 DOI: 10.12688/f1000research.2-136.v3] [Cited by in Crossref: 75] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
629 Zabolotneva AA, Zhavoronkov AA, Shegay PV, Gaifullin NM, Alekseev BY, Roumiantsev SA, Garazha AV, Kovalchuk O, Aravin A, Buzdin AA. A systematic experimental evaluation of microRNA markers of human bladder cancer. Front Genet. 2013;4:247. [PMID: 24298280 DOI: 10.3389/fgene.2013.00247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
630 Agwa E, Ma PC. Overview of Various Techniques/Platforms With Critical Evaluation of Each. Curr Treat Options in Oncol 2013;14:623-33. [DOI: 10.1007/s11864-013-0259-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
631 Gordeladze JO, Djouad F, Brondello JM, Noël D, Duroux-Richard I, Apparailly F, Jorgensen C. Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs. Acta Pharmacol Sin 2009;30:1369-84. [PMID: 19801995 DOI: 10.1038/aps.2009.143] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
632 Manservigi R, Argnani R, Marconi P. HSV Recombinant Vectors for Gene Therapy. Open Virol J 2010;4:123-56. [PMID: 20835362 DOI: 10.2174/1874357901004030123] [Cited by in Crossref: 6] [Cited by in F6Publishing: 26] [Article Influence: 0.5] [Reference Citation Analysis]
633 Kahroba H, Hejazi MS, Samadi N. Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer. Cell Mol Life Sci. 2019;76:1747-1758. [PMID: 30734835 DOI: 10.1007/s00018-019-03035-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 15.0] [Reference Citation Analysis]
634 Liang Y, Wang H, Yang J, Li X, Dai C, Shao P, Tian G, Wang B, Wang Y. A Deep Learning Framework to Predict Tumor Tissue-of-Origin Based on Copy Number Alteration. Front Bioeng Biotechnol 2020;8:701. [PMID: 32850687 DOI: 10.3389/fbioe.2020.00701] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
635 Khoshnaw SM, Green AR, Powe DG, Ellis IO. MicroRNA involvement in the pathogenesis and management of breast cancer. J Clin Pathol 2009;62:422-8. [PMID: 19398594 DOI: 10.1136/jcp.2008.060681] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
636 Labib M, Ghobadloo SM, Khan N, Kolpashchikov DM, Berezovski MV. Four-Way Junction Formation Promoting Ultrasensitive Electrochemical Detection of MicroRNA. Anal Chem 2013;85:9422-7. [DOI: 10.1021/ac402416z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
637 Zaporozhchenko IA, Ponomaryova AA, Rykova EY, Laktionov PP. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities. Expert Review of Molecular Diagnostics 2017;18:133-45. [DOI: 10.1080/14737159.2018.1425143] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
638 Miller DL, Sharon Stack M. MicroRNA Profiles of HPV-Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC). In: Miller DL, Stack MS, editors. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Cham: Springer International Publishing; 2015. pp. 133-52. [DOI: 10.1007/978-3-319-21100-8_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
639 Wan G, Liu Y, Han C, Zhang X, Lu X. Noncoding RNAs in DNA repair and genome integrity. Antioxid Redox Signal 2014;20:655-77. [PMID: 23879367 DOI: 10.1089/ars.2013.5514] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
640 Shaham L, Vendramini E, Ge Y, Goren Y, Birger Y, Tijssen MR, McNulty M, Geron I, Schwartzman O, Goldberg L, Chou ST, Pitman H, Weiss MJ, Michaeli S, Sredni B, Göttgens B, Crispino JD, Taub JW, Izraeli S. MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome. Blood 2015;125:1292-301. [PMID: 25533034 DOI: 10.1182/blood-2014-06-581892] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
641 Tchernitsa O, Kasajima A, Schäfer R, Kuban RJ, Ungethüm U, Györffy B, Neumann U, Simon E, Weichert W, Ebert MP. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol. 2010;222:310-319. [PMID: 20726036 DOI: 10.1002/path.2759] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 7.9] [Reference Citation Analysis]
642 Perge P, Nagy Z, Igaz I, Igaz P. Suggested roles for microRNA in tumors. Biomol Concepts 2015;6:149-55. [PMID: 25870972 DOI: 10.1515/bmc-2015-0002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
643 Ruksha TG, Aksenenko MB, Shvetsova YI. [Molecular and pathomorphological prognostic markers for melanoma: Current approaches and prospects]. Arkh Patol 2015;77:71-7. [PMID: 26485783 DOI: 10.17116/patol201577471-77] [Reference Citation Analysis]
644 Hannouf MB, Winquist E, Mahmud SM, Brackstone M, Sarma S, Rodrigues G, Rogan PK, Hoch JS, Zaric GS. The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study. Pharmacoecon Open 2018;2:255-70. [PMID: 29623630 DOI: 10.1007/s41669-017-0051-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
645 Zhang DY, Seelig G. DNA-Based Fixed Gain Amplifiers and Linear Classifier Circuits. In: Sakakibara Y, Mi Y, editors. DNA Computing and Molecular Programming. Berlin: Springer Berlin Heidelberg; 2011. pp. 176-86. [DOI: 10.1007/978-3-642-18305-8_16] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
646 Humphries B, Wang Z, Yang C. MicroRNA Regulation of Breast Cancer Stemness. Int J Mol Sci 2021;22:3756. [PMID: 33916548 DOI: 10.3390/ijms22073756] [Reference Citation Analysis]
647 He Z, Yi J, Liu X, Chen J, Han S, Jin L, Chen L, Song H. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma. Mol Cancer 2016;15:51. [PMID: 27358073 DOI: 10.1186/s12943-016-0533-3] [Cited by in Crossref: 84] [Cited by in F6Publishing: 88] [Article Influence: 14.0] [Reference Citation Analysis]
648 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
649 Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130. [PMID: 16514137 DOI: 10.1007/s11010-010-0463-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
650 Luo J, Wu J, Li Z, Qin H, Wang B, Wong TS, Yang W, Fu QL, Lei W. miR-375 suppresses IGF1R expression and contributes to inhibition of cell progression in laryngeal squamous cell carcinoma. Biomed Res Int 2014;2014:374598. [PMID: 25184138 DOI: 10.1155/2014/374598] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
651 Chiofalo B, Laganà AS, Vaiarelli A, La Rosa VL, Rossetti D, Palmara V, Valenti G, Rapisarda AMC, Granese R, Sapia F, Triolo O, Vitale SG. Do miRNAs Play a Role in Fetal Growth Restriction? A Fresh Look to a Busy Corner. Biomed Res Int 2017;2017:6073167. [PMID: 28466013 DOI: 10.1155/2017/6073167] [Cited by in Crossref: 52] [Cited by in F6Publishing: 60] [Article Influence: 10.4] [Reference Citation Analysis]